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ABSTRACT 
Examining Stage at Diagnosis and Survival in Three Cancers with Definitive Screening Guidelines 
for Average-risk Adults: The Role of Marital Status 
by 
David John Blackley 
Each year there are more than 350 000 new cases and nearly 100 000 deaths attributed to 
colorectal, female breast, and cervical cancer in the United States.  Screening tests can reduce 
morbidity and mortality associated with these cancers.  Patient marital status has been 
associated with health outcomes, but no study has focused on the relationship of marriage with 
disease stage and survival for the 3 cancers with established screening guidance.  It is critical to 
identify special populations that may be at risk for poor cancer outcomes. 
The objective of this study was to examine the relationship of marital status with disease stage 
at the time of diagnosis and cancer-specific survival among population-based cohorts of 
patients diagnosed with invasive colorectal, breast, or cervical cancers.  Subjects came from 
states or regions reporting to the Surveillance, Epidemiology, and End Results (SEER) tumor 
registries.  The study included more than 243 500 patients diagnosed between January 1st 2004 
and December 31st 2006 with 1 of these 3 cancers and who were followed for a minimum of 3 
years.  Descriptive statistics were calculated to summarize patient demographic and clinical 
characteristics.  Baseline category logit models were fit to evaluate the association between 
marital status and disease stage.  Kaplan-Meier survival curves and Cox proportional hazards 
models were developed to evaluate differences in patient survival across 4 marital status 
categories. 
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Married adults with colorectal, breast, and cervical cancer were diagnosed at an earlier disease 
stage than those who were divorced/separated, widowed, or single.  After controlling for stage 
and demographic factors, married patients also experienced superior cancer-specific survival 
(range: 19-33% better) as compared to those in non-married groups. 
Divorced/separated, widowed, and single adults are a subset of the population that may 
benefit from targeted prevention or care initiatives for cancers than can be detected early.  
Social support networks, selection effects, or other causal mechanisms likely moderate the 
protective association observed between marriage and cancer outcomes.  These findings 
characterize a meaningful disparity in health outcomes. Additional person-level data on 
preventive health behaviors and treatment decisions could help solidify understanding of the 
issue and improve the ability to design effective research, interventions, and policy.   
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CHAPTER 1 
INTRODUCTION 
Burden of Cancer in the United States 
Cancer is an ongoing public health problem in the United States (U.S.), and it is the 
second leading cause of death after heart disease.  According to most recent estimates, there 
are about 1 640 000 new cancer cases and 577 000 cancer deaths in the U.S. each year.1   
Approximately 1 of every 4 deaths in the U.S. is a result of cancer, but it has been estimated 
that approximately one-third of these premature deaths could be avoided with proper 
adherence to screening recommendations.2  Among males, lung/bronchus, prostate, and 
colorectal cancers account for about half of all incident cases; among females, lung/bronchus, 
breast, and colorectal cancers make up half of new cases.1  Within the U.S. population, these 4 
cancers account for about half of all deaths attributed to cancer, with lung cancer the leading 
cause of cancer death in males and females.  Forty-five percent of males and 38% of females 
will be diagnosed with invasive cancer at some point in their lives, but females have a slightly 
higher likelihood than males of developing cancer before age 60 years due to breast cancer’s 
tendency to be diagnosed at an earlier age relative to other cancer types.1   
The U.S. population is likely experiencing its first sustained decline in overall cancer 
mortality since the 1930s.  Among the U.S. male population, overall cancer incidence declined 
by an average of 0.6% per year between 1994 and 2008; an annual decline of 0.5% was 
observed among females until 2006, at which point the rate of decline moderated through 
2008.3  All-cancer mortality rates for both males and females appear to have peaked in the 
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early 1990s, and data suggest the annual decline in overall death rate was approximately 1.5% 
for both sexes from 2004 through 2008.1,3  These decreases in the overall cancer death rate are 
likely a result of a variety of clinical and public health interventions and initiatives applied 
across the cancer continuum, including improvements in primary prevention, screening and 
treatment.3  Incidence rates for 3 of the 4 leading tumor sites mentioned above have declined 
in recent years, with the lone exception being female breast cancer (Figures 1 and 2).4  
Research has linked changes in invasive female breast cancer incidence rates with variations in 
reproductive risk factors, mammography uptake and the prevalence of hormone replacement 
therapy among women.3     
 
Figure 1: Age-adjusted incidence rates, lung/bronchus, prostate, and colorectal cancers 
diagnosed in males, all ages, United States, 2003 through 2009 
13 
 
 
Figure 2: Age-adjusted incidence rates, lung/bronchus, breast, and colorectal cancers diagnosed 
in females, all ages, United States, 2003 through 2009 
Reductions in lung cancer incidence are associated with historical declines in smoking 
prevalence, and declines in colorectal cancer incidence are partially attributed to improved 
uptake of endoscopic and radiologic screening methods capable of detecting, and then 
removing, precancerous growths.5  Mortality rates for lung/bronchus, breast, colorectal, and 
prostate cancers are all decreasing (Figures 3 and 4), with reductions in lung cancer deaths 
accounting for 34%-40% of the overall decline, with slight variation by sex.1,6  Among women 
substantial reductions in breast and colorectal cancer death rates account for more than half of 
the reduction in overall cancer mortality observed in recent years.5,7  Among young men 
leukemia is the most common cause of cancer death, with lung cancer the leading cause after 
age 40 years.  In women leukemia is the leading cause of cancer death until age 20 years, breast 
cancer between 21 and 59 years, and lung cancer after age 60 years.1 
14 
 
 
Figure 3: Age-adjusted mortality rates, lung/bronchus, prostate, and colorectal cancers 
diagnosed in males, all ages, United States, 2003 through 2009 
 
Figure 4: Age-adjusted mortality rates, lung/bronchus, breast, and colorectal cancers diagnosed 
in females, all ages, United States, 2003 through 2009 
Cancer Disparities in the United States 
There are large regional differences in overall cancer incidence and mortality in the U.S., 
and of the major tumor types, lung cancer has the most notable geographic variation.1,8  
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Regional variations are less pronounced for other tumor types, and for cancer that can be 
detected early, state-to-state differences in incidence and mortality usually reflect variations in 
screening uptake, although this doesn’t entirely explain variations in rates.1  In addition to 
region of residence, race/ethnicity is also associated with differences in population cancer 
outcomes.  In the U.S. black men are 15% more likely than white men to get cancer, and 33% 
more likely to die from it; black women are 6% less likely than white women to get cancer, but 
16% more likely to die from it.1  Factors potentially contributing to disparities along racial lines 
vary by cancer type but may include differences in risk factor exposures, screening access, and 
timely and appropriate diagnosis and treatment.9  Cancer incidence and mortality among 
smaller minority groups in the U.S. is lower than in non-Hispanic whites and blacks for most 
cancer types, with the exception of those frequently associated with infectious agents, such as 
cancers of the cervix, stomach, and liver.1 
For lung/bronchus, prostate, colorectal, and breast cancers combined, African 
Americans are more likely than non-Hispanic whites to have regional or distant stage disease at 
diagnosis, most likely predisposing this minority group to a poorer prognosis before treatment 
can even be initiated.10  For nearly every cancer type, 5-year survival is lower among African 
Americans than non-Hispanic whites independent of stage at diagnosis, which may be 
explained by racial disparities in access to care or differences in the presence of comorbidities 
and/or behavioral risk factors.  Although disparities remain, both African Americans and whites 
have experienced marked improvements in 5-year cancer survival since 1975, which are likely a 
result of improved early detection and more effective cancer-directed treatments.1  Two 
prominent cancers that have shown little-to-no improvement in 5-year survival rates in recent 
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years are lung/bronchus and pancreatic cancers, neither of which has widely accepted early 
detection methods.         
Significance of Research 
Survival following a cancer diagnosis largely depends on intrinsic tumor characteristics; 
however, socioeconomic, cultural, and demographic factors may also influence survival to 
varying degrees.11  For cancers with definitive, evidence-based screening recommendations, it 
is critical for researchers and clinicians to be able to identify populations that may be at risk for 
presentation with advanced tumor stage and lower survival relative to the general population.  
National expert panels clearly recommend and provide evidence-based guidance for screening 
among average-risk adults for colorectal cancer, female breast cancer, and cervical cancer.  
These recommendations are based on peer-reviewed science demonstrating that proper 
screening for these cancers reduces morbidity and mortality.12  The primary goal of this 
dissertation is to examine the association of patient marital status with tumor stage at 
diagnosis and survival for the 3 cancer types that have well established screening 
recommendations for the average-risk population.  Research has identified an association 
between marital status and survival for multiple types of cancer, but results have not been 
entirely consistent.  Given the dynamic nature of the institution of marriage (and its varying 
connotations and inherent responsibilities, depending on country of residence), many past 
findings may not be generalizable to the contemporary U.S. general population, because many 
of the studies were conducted in Europe and most are more than a decade old (and use data 
that are decades older still).13   
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No population-based study of marital status’ association with tumor stage at diagnosis 
and survival has been conducted for the 3 cancers with established expert panel screening 
recommendations for the average-risk U.S. adult population.  Developing clear and up-to-date 
information on these associations for each of the 3 cancers in population-based U.S. cohorts 
could increase our understanding of factors that may be associated with the risk of adverse 
prognoses and outcomes. These findings have the potential to improve the knowledge base 
necessary to appropriately design, implement, and evaluate cancer prevention and control 
efforts.    
Research Aims 
Research Aim #1:  Assess differences in tumor stage at diagnosis and survival according to 
marital status among a population-based cohort of males and females diagnosed with invasive 
colorectal cancer between January 1st 2004 and December 31st 2006, while accounting for 
relevant demographic and clinical characteristics.    
Research Aim #2:  Assess differences in tumor stage at diagnosis and survival according to 
patient marital status among a population-based cohort of females diagnosed with invasive 
breast cancer between January 1st 2004 and December 31st 2006, while accounting for relevant 
demographic and clinical characteristics.    
Research Aim #3:  Assess differences in tumor stage at diagnosis and survival according to 
patient marital status among a population-based cohort of females diagnosed with invasive 
cervical cancer between January 1st 2004 and December 31st 2006, while accounting for 
relevant demographic and clinical characteristics.    
18 
 
CHAPTER 2 
LITERATURE REVIEW 
Screening for Cancer 
Effective cancer screening detects disease prior to clinical signs or symptoms.14  Two 
necessary but not independently sufficient criteria for a screening modality to be considered 
effective are that it must identify cancer before it’s detectable based on symptoms alone, and 
that treatment undertaken as a result is likely to elicit an improved outcome relative to if the 
cancer was discovered under normal circumstances.2  Cancers amenable to screening should 
generally be diagnosed at an earlier stage and show an associated improvement in survival 
prognosis.15  A disease-specific mortality reduction in a randomized, controlled prospective trial 
is the strongest form of evidence supporting the candidacy of any proposed screening 
modality.16  Additionally, declines in overall mortality and incidence, improvements in tumor 
stage distribution, and reduced disease-related morbidity may also be considered when 
weighing the benefits and harms of cancer screening.  At the population level, appropriate 
screening for colorectal, female breast, and cervical cancers reduces mortality from these 
diseases.17   
The American Cancer Society (ACS) and the U.S. Preventive Services Task Force (USPSTF) 
develop and regularly update cancer screening recommendations, and guidance from these 
organizations is widely viewed as gold standards for cancer screening in the United States.  
Since 1980 the ACS has updated and published evidence-based guidelines and 
recommendations to foster informed decision-making on screening for cancers of the 
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colon/rectum, cervix, breast, prostate, endometrium, and most recently, lung.  The ACS, in 
collaboration with outside experts, monitors the scientific literature on a continuous basis, and 
generally reviews and/or updates cancer screening guidance every 5 years, with summary 
reviews published annually.12    
The USPSTF, formed in 1984 by the Public Health Service and formally supported by the 
Agency for Healthcare Research and Quality (AHRQ) since 1998, also publishes widely-adopted 
evidence-based cancer screening guidance.  Public Law 106-129 mandates that USPSTF provide 
up-to-date scientific reviews to support evidence-based recommendations for preventive 
services, including cancer screening.18  A screening method’s benefits must outweigh its harms, 
among other criteria, in order for USPSTF to provide a recommendation.  For the most part, 
USPSTF’s recommendations closely resemble those made by ACS, although USPSTF guidance 
tends to be slightly more conservative (i.e. restrictive) with respect to upper and lower limits 
for age groups and recommended screening frequencies.   
Based on the most recent ACS and USPSTF guidance, only 3 cancer sites--colon/rectum, 
female breast, and uterine cervix--have unequivocal screening recommendations for average-
risk U.S. adults.12,18  In 2009, 351 706 new cases of these cancers (133 160 colorectal cancers , 
206 447 female breast cancers, and 12 099 cervical cancers) were diagnosed in the U.S. and 
during 2008 there were 97 454 deaths due to these 3 diseases, a large proportion of which 
could have been detected early or entirely prevented.4  It has been estimated that anywhere 
from 3% to 35% of these premature cancer deaths could have been averted through proper use 
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of screening tests.2  Table 1 presents the ACS’s 2013 estimations for new cases and deaths from 
colorectal, female breast, and cervical cancers, as well as all cancers combined.19   
Table 1: Estimated number of new invasive cases and cause-specific deaths, selected cancer 
sites, United States, 2013       
 
Source:  Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: a cancer journal for 
clinicians. 2013;63(1):11-30. 
Although screening for colorectal, female breast, and cervical cancer is clearly 
recommended for average-risk adults, each of these screening methods has distinct age, sex 
and frequency guidelines, which may differ based on which of the 2 organizations is making the 
recommendations.  In addition, there are certain risks and benefits associated with each 
screening method that a patient should discuss with a clinical provider prior to having the 
screening.12  Cancer screening should be viewed as a process rather than a series of isolated 
procedures, with multiple steps and points of contact between healthcare organizations, 
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clinicians, and patients.17  Any disruptions of this process could lead to a failure to detect cancer 
and increase the likelihood of potentially avoidable morbidity and mortality.  A recent literature 
review of cancer screening found that half of all cervical cancers are diagnosed in women who 
haven’t kept up-to-date with screening, and half of all older women diagnosed with advanced 
breast cancer have never had a mammogram.17  In addition, poor adherence to screening 
guidance likely contributes to the high levels of colorectal cancer mortality in populations with 
low socioeconomic status.20        
Screening Guidance for Colorectal Cancer 
ACS and USPSTF colorectal cancer screening recommendations for average-risk adults 
were each last updated in 2008.  Both organizations recommend average-risk men and women 
begin screening at age 50 years.  USPSTF recommends ceasing screening at age 75 years, while 
ACS does not define an upper age limit in its guidelines.  There are several different colorectal 
cancer screening modalities garnering recommendations, which can be divided into 2 general 
categories:  1) tests that are capable of detecting cancer (includes fecal blood and DNA tests), 
and 2) tests than are capable of detecting cancer and advanced adenomatous polyps (includes 
endoscopic and radiological procedures).12  The distinction between these 2 categories is 
provided to emphasize that prevention of colorectal cancer, and not just early detection, is 
possible, although modalities in each group have unique strengths and weaknesses that should 
be considered prior to choosing a screening method.  ACS and USPSTF recommend an average-
risk adult undergo one of the following:  colonoscopy every 10 years, fecal occult blood test 
(FOBT) every year, or a flexible sigmoidoscopy every 5 years in conjunction with FOBT (every 
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year per ACS guidance and every 3 years per USPSTF).  ACS approves additional alternatives, 
including double-contrast barium enema every 5 years or CT colonography (virtual 
colonoscopy) every 5 years.12,21  USPSTF does not provide guidance on the use of barium enema 
or CT colonography.  In 2010, 17.2% of U.S. adults age 50 years and over reported having had a 
blood stool test in the past 2 years, and 65.2% reported ever having a sigmoidoscopy or 
colonoscopy.22  As of 2010, 58.3% of U.S. adults aged 50 to 75 years were currently meeting 
USPSTF guidelines for FOBT, colonoscopy, or sigmoidoscopy (95% CI 57.0-59.6).23  In a British 
population, van Jaarsveld and colleagues reported that married adults were 23% more likely 
than non-married adults  to report screening for colorectal cancer, and that inviting both 
members of a married couple to screen together further increases uptake.24  Among 21 760 
U.S. adults aged 50 to 85 years, Stimpson et al found that married individuals were 21% more 
likely than the unmarried to report ever having colorectal endoscopy (sigmoidoscopy, 
colonoscopy, or proctoscopy) and 49% more likely to report having an endoscopy during the 10 
previous years.25                
Screening Guidance for Female Breast Cancer 
The ACS breast cancer screening recommendations for average-risk adult females were 
last updated in 2003; USPSTF recommendations were last updated in 2009.  USPSTF 
recommends average-risk women start with screening mammography every 2 years beginning 
at age 50 years, and continue through age 74 years.  ACS recommends average-risk women 
start with clinical breast examination (CBE) as part of periodic health exam (at least every 3 
years) during their 20s and 30s.  ACS guidance supports beginning annual mammography at age 
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40 years, in conjunction with annual CBE, as part of a regular preventive health appointment.  
ACS does not include an upper age limit for mammography in average-risk women.12,26  In 2010, 
75.2% of American women age 40 years and over, and 77.9% of women age 50 years and over 
reported having had a mammogram within the past 2 years.22  Coughlin et al examined data on 
U.S. women age 40 years and over residing in metropolitan areas, and in unadjusted analysis 
found that currently married or cohabitating women (80.4%) were more likely than 
divorced/separated (75.5%), widowed (77.6%) and never married women (72.7%) to report 
receiving a mammogram in the previous 2 years.27  The 95% confidence intervals for the 
married/cohabitating compared to the marriage status groups showed statistical significance  
(p < 0.05).             
Screening Guidance for Cervical Cancer 
The ACS cervical cancer screening recommendations for average-risk female adults were 
last updated in 2002; USPSTF recommendations were last updated in 2012.  USPSTF and ACS 
both recommend women start screening for cervical cancer by age 21 years.  USPSTF 
recommends a Papanicolaou (Pap) test every 3 years for women age 21 years to 65 years, or a 
Pap test/human papilloma virus (HPV) DNA test every 5 years for women age 30 years to 65 
years.  USPSTF doesn’t recommend screening beyond age 65 years for women who have stayed 
current with appropriate screening, or for women who have had their cervix surgically 
removed.  ACS recommends screening women with conventional Pap tests every year, or every 
2 years if using liquid-based Pap tests.  Upon reaching 30 years of age, ACS recommends 
women with 3 consecutive normal test results shift to a Pap test (either method) every 2 to 3 
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years, or every 3 years if a Pap test is done in conjunction with a HPV DNA test.  ACS suggests 
halting screening in women over age 70 years who have had 3 consecutive normal Pap tests 
and no abnormal results during the previous 10 years, or women who have had their cervix 
completely removed.12,28  In 2010, 81.3% of U.S. women age 18 years and over reported having 
had a Pap test in the past 3 years.22  Coughlin et al examined data on self-reported rates of Pap 
testing among American women age 18 years and over living in metropolitan areas, and found 
in multivariate analysis that divorced/separated and widowed women were approximately 30% 
less likely to report a Pap test during the previous 3 years than those who were currently 
married or cohabitating (OR=0.72, 95% CI 0.61-0.85 for divorced/separated and OR=0.69, 95% 
CI 0.56-0.84 for widowed).  Never-married women were much less likely than the currently 
married or cohabitating to report a Pap test in the previous 3 years (OR=0.29, 95% CI 0.25-
0.34).29  Hewitt et al examined a separate, nationally representative sample and came to a 
similar conclusion.  In adjusted analysis, they found that formerly married women between the 
ages of 25 and 64 years were 25% less likely than currently married women to report a Pap test 
during the previous 3 years, and never married women were half as likely to report screening.  
The positive association between marriage and reported cervical cancer screening was even 
more pronounced in women 65 years of age and older.30  Table 2 presents a summary of the 
prevalence of adults in the U.S. who report being ‘up-to-date’ with recommended evidence-
based clinical preventive cancer guidelines, per the recommendations of 2 leading 
organizations.             
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Table 2: Prevalence (%) of U.S. adults up-to-datea with recommended cancer screening per U.S. 
Preventive Services Task Force (USPSTF) and American Cancer Society (ACS) guidance, 2010, 
with comparison to Healthy People 2020 goalsb 
 
a Up-to-date according to most recent published USPSTF and ACS guidance 
b 
Healthy People 2020 Goals screening prevalence goals refer to USPSTF recommendations 
 
Although cancer develops within an individual person, its development is not 
independent of external factors.  Decades of scientific literature have suggested that both 
patient-level and environmental factors can influence tumor characteristics and cancer 
outcomes.31  Important factors directly affecting cancer survival, such as tumor stage, grade 
and lymph node involvement, are fundamental to the disease itself; other factors associated 
with survival may be external in nature.13  Research exploring the determinants of disparities in 
stage at diagnosis and survival for various cancers has identified socioeconomic, cultural, 
geographic, biomedical, and genetic factors as associated with variations in outcomes across 
different population groups.  Survival data broken down by racial and/or ethnic groups have 
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played an essential role in helping clinicians and public health researchers identify at-risk 
populations that may not be receiving adequate attention with respect to preventing and 
treating cancers that can be detected early.15  It is also important to identify clinical and 
socioeconomic characteristics that may contribute to disparate survival patterns across groups, 
so as to improve the reach and cost-effectiveness of public health interventions.   
Marriage in America 
Marriage, and the responsibilities and expectations it entails, has different meanings in 
different contexts.  Family structure norms in the U.S. have undergone radical change in recent 
decades.  Economic and cultural forces have shifted societal standards for marriage, divorce, 
cohabitation, childbirth, sexual behavior, and women’s roles in the home and workplace.32  
Nearly all Americans still consider marriage and married life the ideal family structure, but the 
institution is increasingly perceived as optional, and the notion of traditional marriage as a 
dominant family and social structure has been on the decline for decades.32,33  Residents of the 
U.S. have an increasingly broad definition of what constitutes a ‘family,’ and nearly all adults 
cite their own family, in whatever form it takes, as the most important aspect of their lives.  In 
recent decades, there has been a sharp decline in the proportion of American adults who are 
married, a trend shaped by opinions, attitudes, and behaviors that vary by age, race/ethnicity, 
and class.  Fifty-one percent of all adults living in the U.S. are currently married, the lowest 
proportion in recorded domestic history.  In 1960, 72% of U.S. adults were married.34  The 
median age at first marriage in U.S. men (28.7 years) and women (26.5 years) has never been 
higher than it is now.32,35  Researchers have observed declines in marriage rates among all age 
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groups, but these are most pronounced in the younger population, with only 20% of adults age 
18 to 29 years currently married compared to 59% in 1960.35  It is still impossible to know 
whether contemporary young adults are simply delaying marriage or increasingly abandoning it 
altogether, but contrary to widespread opinion, there is historical precedent for a reversal in 
the slope of the marriage curve.   
Current social commentators, many of whom grew up in 1950s post-war America, often 
refer to that era as the normal “baseline” for the prevalence of marriage.  However, average 
age at first marriage (for men and women) was at an historic low in the 1950s and is an 
anomaly compared to other time periods.32  This does not diminish the cultural significance of 
the shifts observed in recent years.  An increasingly egalitarian labor division has emerged 
between men and women, conferring new societal and individual benefits, as well as 
stressors.33  Young adults, both married and unmarried, now have expanded options for 
housing, employment and education.  The unmarried are currently much more likely than in the 
past to live alone, which could signify a major shift in the composition of important social 
support systems.32  Childless unmarried cohabitation, as well as single-parent childrearing, has 
also become more prevalent, and decades of data suggest these trends are not related to 
economic cycles.35  About half of U.S. adults cohabitate prior to nuptials, and increasingly, this 
arrangement evolves into an permanent informal substitute for marriage.32  In a recent survey, 
nearly 40% of Americans said marriage is becoming obsolete, but more than 60% of the 
unmarried individuals in the same sample said they would like to marry someday.35  Along with 
never-married adults, American communities have become increasingly supportive of single 
parents and divorcees.33   
28 
 
Although the broad societal trend has been towards a reduction in the overall 
prevalence of marriage, some researchers have identified the emergence and growth of a so-
called “marriage gap” in America.34  This “gap” exists between groups defined by race, income, 
and education.  As of 2010, 51% of all U.S adults were married, 14% were divorced or 
separated, 6% were widowed, and the remaining 28% were never married.  However, when 
stratified by race, 55% of white, 48% of Hispanic, and only 31% of black adults were married.35  
This gap is increasingly aligned with growing income disparities in the country.34  The recent 
decline in the marriage rate has been much less precipitous among those with college 
educations, with current college graduates 17% more likely to be married than those with a 
high school education or less.35  These underlying trends have led some to label this 
phenomenon as a “class-based” decline in marriage, highlighting systemic influences on the 
role of marriage in our society.34  It has been hypothesized that additive effects of these 
complex societal changes, compounded over time, may be contributing to expanding mortality 
inequalities observed between married and unmarried populations.33  Recent opinion polls 
asking about the acceptability of emerging nontraditional family structures found that the 
young were more accepting than the old, political liberals were more accepting than 
conservatives, and the secular were more accepting than the religious.  Women have 
essentially achieved parity with men with respect to overall workforce composition and 
educational achievement, so it will be interesting to monitor how sex interacts with class-based 
variables to influence marriage trends.34  
Recent declines in marriage rates have been substantial, but Americans are still more 
favorably inclined to marriage than residents of other developed countries.32  Although 
29 
 
marriage rates are higher in the U.S. than in Europe and first world nations, the U.S also has 
substantially higher divorce rates, although these have diminished over the last 20 years after 
climbing consistently during the 1960s and 1970s.35  One-third of marriages starting in the 
1950s ultimately ended in divorce, compared to almost half in recent years; the nation has 
experienced something resembling a left-skewed bell curve over the past 60 years with respect 
to divorce rates.32  Although the general public no longer sees marriage as the only path to a 
happy family life, or as a sacrament that can only be broken in extremely rare circumstances, 
the institution will no doubt continue to be promoted as a preferred lifestyle, both explicitly 
and implicitly.33,34  Major religious institutions continue to promote marriage as the ideal family 
structure, and the U.S. Federal government has formally endorsed marriage in legislation.  The 
Personal Responsibility and Work Opportunity Reconciliation Act of 1996, passed by the 104th 
Congress and signed by President Bill Clinton, clearly identified marriage as a foundation and 
essential institution of a successful society.36           
Marital Status, Cancer Stage at Diagnosis, and Survival 
Many researchers have identified an association between marital status and overall 
mortality.  A recent international meta-analysis designed to estimate excess mortality in 
unmarried elderly individuals showed an overall relative risk of 0.88 [95 % CI: 0.85-0.91] in the 
married compared to the non-married, with minimal variation when results were stratified by 
sex.37  The researchers found some evidence of publication bias, but ultimately their overall 
estimate was consistent across several methodological approaches and sensitivity analyses.  It 
has been suggested that the protective association between marriage and mortality is likely a 
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result of enhanced support networks inherent to married and family life as well as the generally 
high regard for married relationships in modern Western society.33  While this association has 
been documented in the U.S. and Europe for both overall and disease-specific mortality in past 
decades, the institution of marriage and its defining characteristics has undergone substantial 
change in recent years, with modern society becoming increasingly accepting of never-married 
adults, single parents, and divorcees.33,38-40  Americans across the socioeconomic spectrum still 
view marriage as the ideal family structure, but increasingly this belief does not translate itself 
into practice.32        
In 1987, Goodwin et al were among the first to identify a favorable association between 
marital status and likelihood of cancer diagnosis, treatment, and survival using population-
based data.41  It was already widely accepted that married individuals tended to live longer and 
experience lower all-cause mortality, but Goodwin and colleagues demonstrated that 
unmarried cancer patients were more likely to be diagnosed at an advanced tumor stage, more 
likely to remain untreated, and prone to poorer overall survival.  Their approach of controlling 
for beneficial factors at the diagnostic, treatment, and response stages highlighted marriage’s 
positive and independent influence at multiple stages of the disease process.  The findings of 
this study will be discussed further in subsequent sections. 
Most research focused on specific cancer types has found a protective effect of 
marriage, with cancer generally diagnosed at an earlier stage, and patients more likely to 
receive recommended therapy, but population-based research has also demonstrated 
conflicting findings about the association between marital status and stage, treatment, and/or 
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survival.38,40  In fact, 2 separate research groups analyzed recent population based cancer 
registry data on bladder cancer patients, and arrived at contradictory conclusions.11,13  Both 
studies examined outcomes in bladder cancer patients from the same nationally representative 
cancer registry during nearly identical timeframes (those diagnosed between 1973 and 2000 in 
the Gore study, 1973-2002 in the Nelles study), but Nelles considered all bladder cancer 
patients (n=127 015) while Gore restricted analysis to those who’d had radical cystectomy for 
transitional cell carcinoma of the bladder (n=7 262).  Gore et al found that being married was 
associated with improved survival from bladder carcinoma relative to unmarried patients, 
independent of multiple factors known to influence survival, such as stage at diagnosis, gender, 
age, and race/ethnicity.  In contrast, Nelles et al analyzed population-based data from the same 
registries and found that marriage did not seem to confer a definitive survival advantage for 
bladder cancer patients after controlling for relevant confounders.  The differences observed in 
seemingly similar patient populations could be due in-part to potential lead time bias in Gore’s 
subset population.  There may be no true bladder cancer outcome benefit conferred by marital 
status, but married patients may be more likely to undergo cystectomy early, creating the 
illusion of longer survival when they could simply be experiencing better post-procedure 
survival.  Nelles et al stratified their population to try to detect this same effect among those 
who’d had a cystectomy, but no such association was detected.  Another factor potentially 
influencing this observed difference for the same tumor type was that Gore and colleagues 
considered overall survival, while Nelles et al calculated cancer-specific survival (death from any 
cancer).  In other words, the marriage-survival benefit observed by Gore may have been 
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accounted for by deaths from ‘other causes’ in the non-married subsets of their bladder cancer 
patient populations.    
Marital Status and Colorectal Cancer 
In 1987 Goodwin et al were among the first to study the association between marital 
status and stage, treatment, and survival in patients diagnosed with cancer.  They examined 
tumor registry data representing all Hispanic and non-Hispanic white New Mexico adults (age 
20+ years) diagnosed between 1969 and 1982.  They separated cancers of the colon and rectum 
for statistical analysis and found that unmarried patients had slightly higher likelihood of 
nonlocal (regional or distant) disease at diagnosis for both cancers, but the odds ratio was not 
statistically significant.  After controlling for tumor stage at diagnosis, unmarried rectal (but not 
colon) cancer patients were significantly less likely to receive definitive treatment.  Upon 
controlling for stage and treatment, unmarried colon cancer patients had a significantly 
elevated risk of death (RR=1.27, 95% CI 1.11-1.45), but risk was not elevated in rectal cancer 
patients (RR=0.97, 95% CI 0.84-1.28).41  In 1996 Johansen et al studied a cohort of Danish 
patients diagnosed with colon or rectal cancer between 1968 and 1972, which allowed for 
follow-up of more than 2 decades.  Of the 7 302 individuals eligible for the study, married colon 
cancer patients demonstrated significantly better 5-year survival than unmarried patients, even 
after controlling for extent of disease (RR=0.85, 95% CI 0.78-0.93), but there was no survival 
difference observed in rectal cancer patients in the same cohort.42  In 2010 Lai et al analyzed 
the association between marital status and stage and diagnosis and survival in 72 214 U.S. 
colon (rectum excluded) cancer patients (adults age 50 to 75 years) diagnosed between 1992 
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and 2003.  After adjusting for stage at diagnosis, they found that single patients had a 23% 
higher risk of death compared to married patients, but this elevated risk was less pronounced 
among widowed, separated, and divorced patients.  Unmarried patients were also more likely 
than married patients to be diagnosed with advanced stage colon cancer.  The apparent 
survival benefit in married individuals diminished once researchers controlled for stage at 
diagnosis in survival models, suggesting that the protective benefit of marriage on cancer 
survival may be explained in-part by its impact on stage at diagnosis.43  In 2011 Wang et al 
examined this association in a U.S. population, again only in colon cancer patients.  They 
analyzed national data on 127 753 patients diagnosed with colon cancer between 1992 and 
2006 and found that married patients were more likely to be diagnosed at an earlier stage 
compared to single, separated, and divorced patients, and they were more likely to receive 
definitive surgery than all unmarried (including widowed) individuals.  Controlling for age, race, 
tumor stage, and receipt of surgery, married colon cancer patients had lower risk of death than 
single patients (hazard ratio (HR) in males, 0.86, 95% CI 0.82-0.90; in females, HR 0.87, 0.83-
0.91).38            
Marital Status and Female Breast Cancer 
Goodwin and colleagues also examined the effect of marital status on female breast 
cancer survival.  They found that unmarried women had an increased likelihood of nonlocal 
disease at the time of diagnosis (OR 1.24, 95% CI 1.09-1.42) and of failing to receive definitive 
treatment (OR 1.34, 95% CI 1.02-1.76).  However, after controlling for these 2 factors, there 
was no association between marriage status and risk of death in female breast cancer patients 
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(RR 1.03, 95% CI 0.92-1.16).41  In 2005, Osborne at al published nationally representative data 
on U.S.-resident women diagnosed with breast cancer between 1991 and 1995.  Of the 32 268 
women age 65 years and older in the study population, unmarried women were more likely 
than married to be diagnosed with late-stage (II-IV) cancer compared to early stage (I or in situ) 
cancer (OR 1.17, 95% CI 1.12-1.23).  Unmarried women with early stage disease were also less 
likely than married women to receive definitive treatment.  Upon controlling for stage at 
diagnosis and treatment received, unmarried women were 25% more likely than married 
women to die from breast cancer during the study period (95% CI 1.14-1.37).  These data were 
linked with Medicare records, which increased the amount of individual-level data available for 
each patient.  However, within this large cohort, patient socioeconomic status and 
comorbidities ultimately had minimal impact on the independent association between marital 
status and breast cancer survival.44      
Marital Status and Cervical Cancer 
Goodwin et al also examined data on New Mexico’s Hispanic and non-Hispanic white 
women diagnosed with cervical cancer between 1969 and 1982, and found a marginally 
significantly increased likelihood of nonlocal disease at time of diagnosis in the unmarried (OR 
1.35, 95% CI 1.00-1.84).  However, after controlling for stage at diagnosis, unmarried women 
were much less likely than married to receive definitive treatment for cervical cancer (OR 3.41, 
95% CI 1.77-6.55).  Finally, when controlling for stage at diagnosis and receipt of treatment, 
there was no statistically significant difference in risk of death between married and unmarried 
women (RR 1.25, 95% 0.96-1.60).41  In 1990, Murphy et al published research examining 
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survival among 1 728 women in southeastern England diagnosed with cervical cancer between 
1972 and 1981.  Although the researchers observed an apparent difference in crude survival by 
marital status, this difference was accounted for after controlling for variations in age and stage 
by marital status, at which point it became clear that there was no significant difference in 
survival by marriage category.45  In 2010 Patel et al similarly found that among 7 997 women in 
a nationally-representative U.S. sample of patients diagnosed with cervical cancer between 
1992 and 1996, being married initially seemed to be associated with better 5-year survival 
among the married compared to the unmarried.  However, this advantage vanished once the 
researchers corrected for tumor stage at diagnosis and receipt of definitive treatment, 
suggesting that marriage’s role may be more pronounced in the portion of the cancer 
continuum associated with early diagnosis and/or treatment decisions.  In other words, most of 
the observed survival benefit in this married population could be attributed to earlier stage at 
diagnosis and/or higher likelihood of receiving radiation therapy.46    
Mechanisms Potentially Explaining the Association 
Several mechanisms have been suggested to explain the association between marriage 
and improved cancer outcomes, but the selection effect and social causation are 2 theories 
frequently mentioned in the literature.33,38,40  The selection effect, sometimes called health 
selection or marriage selection, is based on the premise that healthy people may be more likely 
than unhealthy people to get and stay married.33,38  In other words, good health may not be a 
result of being married, but rather, marriage a result of good health.38  Kaplan et al suggested 
that those who are seriously ill, or more likely to become seriously ill, may be perceived by 
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others as less suitable marriage partners than those with a history of good health.  Their 
findings offer support for this idea, because within the population they studied, the 
disadvantageous association between marriage status and mortality was stronger in those who 
were never married than in those who had been married but had divorced or been widowed at 
a later date.47   
Social causation is the idea that social networks, or in this case marriage and the close 
familial bonds that commonly come with it, provide important emotional support, cultivate 
positively influential relationships, and encourage healthful behaviors.33,38  In as much as these 
benefits are gained through transition into the married state, it has also been suggested that 
loss of some of this support system, whether through divorce or widowing, could increase risk 
of cancer-related morbidity and mortality.33  In a more tangible sense, encouragement from a 
spouse may influence someone to elect to undergo screening, or pursue a more aggressive 
treatment, which could advantageously influence stage at the time of diagnosis and survival 
respectively.38  In those who’ve been diagnosed with a potentially treatable cancer, the 
presence and support of a spouse may convince them that there is “more to live for.” 
The Surveillance, Epidemiology, and End Results (SEER) Program 
The Surveillance, Epidemiology, and End Results (SEER) program collects data from 
tumor registries across the U.S.  SEER is a standard of quality in the field of cancer outcomes 
research and is the definitive source for population-based cancer incidence and survival data in 
the United States.38,48  SEER disseminates population-based cancer data on patient 
demographics, tumor site and morphology, extent of disease and treatment course, with 
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follow-up to monitor vital status.49  The broad goals of the SEER Program are 4-fold: 1) report 
regularly and accurately on U.S. cancer incidence, mortality, prevalence, and survival,                
2) identify and monitor unusual cancer incidence trends in demographic and geographic 
subpopulations, 3) report on trends in cancer stage at diagnosis and treatment/therapy 
decisions, and 4) encourage research that promotes identification of factors to improve 
effectiveness of comprehensive cancer control initiatives.49  The SEER Program is financially 
supported by the National Cancer Institute (NCI) and the Centers for Disease Control and 
Prevention (CDC).  SEER’s Public Use Database is maintained by personnel from NCI’s Division of 
Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics 
Branch.40,48   
In 1971 the National Cancer Act established the authority to collect, analyze, and share 
national data relevant to cancer prevention, diagnosis, and treatment.49  In early 1973 the SEER 
program started collecting data in 5 states and 2 metropolitan areas, and it has since expanded 
to include tumor registries around the country.  SEER now reports cancer-related data for 
residents of Connecticut, Hawaii, Iowa, New Mexico, Utah, California, Georgia, Kentucky, 
Louisiana, New Jersey, the Detroit and Seattle/Puget Sound metropolitan areas, and Alaska 
Natives and American Indians in Arizona.48  Participating SEER regions and states were chosen 
because they contained epidemiologically important and/or representative population groups 
and possessed the capacity to maintain a population-based tumor registry system and regularly 
report accurate data.  Currently, SEER-participating registries collect and report cancer-related 
data covering 28% of the U.S. population, with some oversampling for recognized racial/ethnic 
minorities.  Seventy-one percent of Hawaiian/Pacific islanders, 54% of Asian Americans, 43% of 
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American Indians/Alaska natives, 41% of Hispanics, and 26% of African Americans residing in 
the country are covered by SEER-participating registries.  As of the most recently reported 
diagnosis year, SEER registries have reported detailed information on more than 7 million 
diagnosed cancer cases, with cases diagnosed since 2001 having tumor site and histology coded 
according to International Classification of Diseases for Oncology, third edition (ICD-O-3) 
standards.49,50   
Collectively, the sub-populations comprising the SEER registries are nearly identical to 
the broader U.S. population with respect to education and poverty levels, but the SEER 
population has a higher proportion of foreign-born (17% vs. 11%) and urban (88% vs. 79%) 
participants than the broader populace.48  State and regional registries participating in SEER 
report all incident cancers diagnosed in their geographic areas each year.49  Participating 
registries regularly conduct both passive and active cancer case follow-up; patient vital status is 
verified through state and national death records, Health Care Financing Administration and 
Social Security Administration files, voting, credit, and driver license records, and 
hospital/physician records.15  The SEER Program complements these data with annual mortality 
reports from the National Center for Health Statistics (NCHS).  NCHS data include information 
on deceased individuals in the geographic areas of interest, including age, sex, and 
underlying/contributing causes of death.49  To assure accurate reporting of cancer incidence 
and outcomes, SEER allows 22 months to elapse between the end of a diagnosis year and the 
time of report to NCI.  With each annual spring data release, existing case records from 
previous years are updated if new patient information is available or entirely new diagnoses 
from that time period (i.e. missed cases) are reported to registries.  Historically, an initial annual 
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SEER case count is about 2% below the total count that will eventually be registered for that 
year.49 
Cancer Staging in SEER 
Extent of disease at the time of diagnosis is an important determinant of cancer 
treatment course and is often a useful outcome predictor.  Two prominent cancer staging 
systems used in the U.S. include the American Joint Committee on Cancer’s (AJCC) Cancer 
Staging Manual, commonly referred to as the TNM (tumor-node-metastasis) System, and the 
Summary Staging System.51  The AJCC-maintained TNM System is predominantly used by 
clinicians, with the ‘tumor’ component describing the invasiveness and size of the primary 
tumor, the ‘node’ component describing the presence or absence of the cancer in nearby 
lymph nodes, and the ‘metastasis’ component indicating whether or not there are distant 
metastases and/or distant lymph node involvement.52   
The SEER Program has developed a modified version of the Summary Staging System, 
made possible through its consistent documentation of various characteristics relevant to 
extent of disease.  Data on extent of disease are more specific than stage alone, which allows a 
cancer staged in the SEER system to remain comparable across multiple generations of AJCC 
stage definitions.53  This characteristic of the SEER system is well suited to its primary use, 
because SEER staging is used for population-based longitudinal research, while AJCC staging is 
more commonly used in the clinical setting to inform decisions related to individual patient 
prognosis.  SEER staging can be used for all solid tumors but not for leukemias.  It combines 
information from medical records, clinical findings, and pathological reports.52  SEER summary 
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staging consists of 5 categories:  in situ, localized, regional, distant, and unstaged.  A separate 
localized/regional category applies only to prostate cancer cases and is not used in this study.54  
Cancers coded in SEER as in situ are non-invasive tumors without malignant behavior that 
haven’t extended through the basement membrane or beyond the epithelium.  A localized 
cancer is confined to the organ of origin, with rare exceptions, such as limited intraluminal 
extension in colon cancer, assuming no lymph node involvement.  Regional cancer has spread in 
one of the following ways: 1) directly into surrounding tissue or organ(s), 2) into nearby lymph 
nodes via the lymphatic system, or 3) via a combination of these 2 routes.  Cancer classified as 
distant has spread to parts of the body away from the primary tumor, via direct growth, 
discontinuous metastasis to other organs, or to distant lymph nodes via the lymphatic system.54                        
Summary Statement 
Much of the research described in preceding sections focused on the association 
between marital status and stage, treatment, and outcomes for cancers originating in the 
prostate, brain, bladder, kidney, and pancreas.11,13,31,39,40,55-57  While the findings are certainly 
interesting and informative, those cancers do not have evidence-based early detection 
methods likely to reduce mortality or morbidity.  The focus of the current study is limited to the 
3 cancer types for which there are screening methods proven to reduce mortality.  Any findings 
on protective associations for colon, cervical, and breast cancer have more potential for 
translation to practices that could improve actual health outcomes.  An enhanced 
understanding of the effect of marital status on stage at diagnosis and ultimately cancer 
survival could help clinicians and public health professionals identify subset(s) of the U.S. 
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population at risk for adverse cancer-related outcomes, or who could stand to benefit from 
targeted cancer prevention and control efforts.      
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CHAPTER 3 
METHODS 
Based on a review of the literature, this appears to be the first population-based study 
examining the association of marital status with tumor stage at diagnosis and survival for 
cancers with definitive screening recommendations for the average-risk adult population.  The 
SEER Program, described previously, collects cancer patient data which is used for the analysis 
in this study.  Upon signing a data-use agreement, these data were made accessible through 
the SEER Limited-Use database.  The East Tennessee State University Office for the Protection 
of Human Research Subjects has determined that this research proposal does not meet 
established definitions for research involving human subjects and does not require Institutional 
Review Board (IRB) approval.  The University has issued a letter of exemption regarding human 
subjects’ research.     
The methods consist of the 3 following major components: 
1. Descriptive statistics characterizing the 3 distinct patient populations 
2:  Bivariate and baseline category logit analysis of the association between marital 
status and disease stage at the time of diagnosis; the latter will include steps to control 
for confounding and assess effect modification   
3:  Development of Kaplan-Meier survival curves and Cox proportional hazards models 
describing differences in patient survival across marriage categories while accounting 
for potential confounders       
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Overall Patient Population 
Using the Case Listing Session function of the National Cancer Institute’s SEER*Stat 
software version 8.0.1, all invasive primary site colon/rectum, female breast, and uterine cervix 
cancers diagnosed between January 1st 2004 and December 31st 2006 in adults residing in a 
SEER-participating state or region are identified and followed through November 2011.  These 
diagnosis dates are chosen to allow for up to 6 years and no less than 3 years of survival follow-
up for all patients, depending on the date of diagnosis.  Case data are downloaded using 
SEER*Stat and the results matrix containing patient records is imported into SAS version 9.2 
(Cary, North Carolina) for analysis.  De-identified patient records include information on patient 
demographics, tumor characteristics, and outcomes.  The minimum age for patient inclusion in 
the cohorts reflects the most liberal guidance for initiation of screening (specific to each tumor 
site) within the average risk adult population according to evidence-based recommendations 
made by ACS and USPSTF.  Cancer anatomic site is categorized according to International 
Classification of Diseases for Oncology, 3rd Edition (ICD-O-3) standards.   
Colorectal Cancer Cases 
ICD-O-3 tumor site codes C18.0-C18.9, C19.9 and C20.9 are designated cancers of the 
colon/rectum.54  These site codes include tumors originating in the cecum, appendix, ascending 
colon, hepatic flexure, transverse colon, splenic flexure of the colon, descending colon, sigmoid 
colon, rectosigmoid junction, overlapping lesions of the colon, and those originating in the 
colon or rectum that are not otherwise specified (NOS).   Lymphomas originating in lymphatic 
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tissue of the colon/rectum are excluded.  Minimum age for inclusion in the cohort is 50 years.   
There is no upper age limit for inclusion.   
Female Breast Cancer Cases 
ICD-O-3 tumor site codes C50.0-C50.9 are designated cancers of the female breast.54  
These include tumors originating in the nipple, central breast, upper-inner, lower-inner, upper-
outer and lower-outer quadrants, and axillary tail of the breast, as well as overlapping lesions of 
the breast and breast tumors not otherwise specified (NOS).  All male breast cancers and skin 
cancers originating in breast tissue are excluded from analysis.  Minimum age (at the time of 
diagnosis) for inclusion in the cohort is 40 years.  There is no upper age limit for inclusion. 
Cervical Cancer Cases 
ICD-O-3 tumor site codes C53.0-C53.9 are designated cancers of the uterine cervix.54  
Only females are included in analysis.  These site codes include tumors originating in the 
endocervix, exocervix, cervix uteri, and overlapping lesions of the cervix uteri.  Minimum age 
for inclusion in the cohort is 20 years.  There is no upper age limit for inclusion.   
Independent Variable 
The independent variable is patient marital status at the time of diagnosis report to the 
registry for the referent tumor.  During the time frame of this study, there were 6 possible 
categories in the SEER database for marital status: 1) married (including common law marriage), 
2) single (never married), 3) separated, 4) divorced, 5) widowed, and 6) unknown.58  If a patient 
declares him/herself married at the time of diagnosis, then it is reported as such (SEER defines 
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marriage as a self-reported state).  Separated and divorced are combined into one category 
(divorced/separated) per research precedent, but other categories remain as defined by the 
SEER program.11  Completeness of the marital status variable within SEER was 95% for patients 
diagnosed from 1973-2007, with minimal variation in completeness by patient vital status.    
Stage at Diagnosis 
SEER Historic Stage A, a unique summary stage for tumors, is used to categorize cancer 
stage at the time of diagnosis.54  Historic Stage A is created by collapsing comprehensive extent 
of disease information collected by the SEER Program, and stage categories relevant to this 
analysis include in situ, localized, regional, distant, and unstaged.  Patients with tumors lacking 
malignant behavior and those with tumors left unstaged are excluded from analysis.  
Covariates 
Other patient variables included in analysis are sex (for colorectal cancer only), race, 
age, education, household income, and residential status.  Modeled small area estimates of the 
percentage of the female population with a mammography in the past 2 years and a Pap test 
within the past 3 years are also available for breast and cervical cancer patients.   
The sex variable categorizes the patient as either male or female at the time of diagnosis.  For 
publication purposes, the SEER Program collapses specific racial categories into white, black, 
other (defined as American Indian/Alaska Native, Asian/Pacific Islander), unspecified, and 
unknown.  The age variable refers to the patient’s age in years at the time of tumor diagnosis.  
The age variable is treated as a categorical variable and stratified according to research 
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precedent and the recommended age range for each screening modality.  For colorectal cancer 
patients, age is categorized into 4 groups: 50-59 years, 60-69 years, 70-79 years, and 80 years of 
age or greater.  Female breast cancer patients are categorized in 5 age groups: 40-49 years, 50-
59 years, 60-69 years, 70-79 years, and 80 years of age or greater.  Cervical cancer patients are 
also divided into 5 age groups: less than 40 years, 40-49 years, 50-59 years, 60-69 years, and 70 
years of age or greater.  Residential status, income, and education are county-level attributes 
using U.S. Census Bureau data.59  For the educational attainment variable, percentage of county 
residents age 25 years and older with less than a high school education was linked to the 
individual patient record.  For the income level variable, median household income in the 
county of residence was linked with the patient record.  For residential status, the Rural-Urban 
Continuum Code, developed by the U.S. Department of Agriculture, is used to characterize the 
population size of the patient’s county of residence.  Rural-Urban Continuum Codes 
characterize metropolitan counties by the population size of the metropolitan area(s) within 
their borders, and nonmetropolitan counties by the degree of urbanization within and adjacent 
to metropolitan area(s) in neighboring counties.  Codes developed in 2003 are used for analysis.  
Rural-Urban Continuum Codes have 9 categories ranging from counties in metropolitan areas 
with greater than 1 million residents to completely rural counties with less than 2 500 residents 
not adjacent to a metropolitan area.59  Categories 1 through 3 are metropolitan with 
populations of at least 250 000 persons, and categories 4 through 9 are nonmetropolitan, 
ranging from small urban areas adjacent to metropolitan areas down to sparsely populated 
rural and frontier areas not adjacent to metropolitan centers.  Due to limitations of Rural-Urban 
Continuum Code availability for the state of Alaska, all patients from this SEER registry are 
47 
 
classified as nonmetropolitan for analysis.  The modeled small area estimates for breast and 
cervical cancer screening are developed by the National Cancer Institute using Behavioral Risk 
Factor Surveillance System (BRFSS) and National Health Interview Survey (NHIS) data.  These 
estimates are ecological and available at the health service area (HSA) level.            
Descriptive Statistics 
Descriptive statistics and clinical characteristics of the patient population for male and 
female colorectal, female breast, and cervical cancer patients are summarized in table format, 
and chi-square tests are used to assess unadjusted associations between categorical variables.  
Ecological county-level attributes are not characterized descriptively because they don’t 
represent individual-level characteristics.  Patients with missing information for marital status, 
tumor stage, age and/or race are excluded.38      
Baseline Category Logit Models 
Following the descriptive analysis, the next step is determination of the likelihood of 
advanced stage cancer (regional or distant) at the time of diagnosis.  Bivariate associations 
between potential covariates and the outcome variable stage at diagnosis are calculated, with 
those covariates showing independent statistically significant associations (at p=0.05) with the 
outcome eligible for inclusion in the multiple regression models.  Baseline category logit models 
are then fit for each of the 3 patient cohorts.  This is an unconditional, nominal logistic multiple 
regression model with the dependent variable stage.  The 2 non-reference categories (regional 
and distant disease) are contrasted with the baseline referent (localized disease).   The Logistic 
Procedure in SAS software fits these models using a maximum likelihood estimation when the 
48 
 
generalized logit option (LINK=GLOGIT) is specified in the MODEL statement.  Analysis includes 
assessment for effect modification between marital status and relevant covariates such as sex 
and race.    
Patient Survival Time and Follow-up 
Survival time can’t be analyzed as a simple continuous outcome variable because time 
to event is not known for all patients.  Because patients are diagnosed with cancer at different 
points in the study period, follow-up time differs across each of the 3 cohorts.  By taking follow-
up time into account, the power and precision of results are improved.  Survival time is 
measured in months from the time of cancer diagnosis with adjustment for censoring from any 
of the following conditions: 1) patient is lost to follow-up; 2) patient dies from any non-cancer 
cause; 3) patient survives to the end of the follow-up portion of the study period.  Patients are 
followed for up to 6 years, and for a minimum of 3 years, to allow for sufficient data for survival 
analyses while still assuring a contemporary patient population.  It is necessary to restrict 
analysis to patients diagnosed after January 1st, 2004, because before that time the SEER 
Program derived summary tumor stages (including SEER Historic Stage A) using outdated extent 
of disease information that have limited comparability across time.  The 2011 SEER Program 
data submission, made public in April 2012, contained a patient follow-up cutoff date of 
December 31st, 2009.54      
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Survival Analysis 
Separate survival analyses are conducted for each of the 3 cancer patient cohorts.  Each 
survival analysis specifies death resulting from any cancer as the outcome of interest (patient 
failure).  This outcome is used because death from any cancer may not be independent of the 
primary tumor in a population already diagnosed with invasive cancer, especially when 
considering that post-diagnosis follow-up consists of no more than 6 years for any given 
patient.13  Population-based research evaluating agreement between initial cancer diagnosis 
and coded cause of death found that approximately 85% of deaths within the first decade of 
follow-up were attributed to the tumor-specific diagnosis listed in SEER, but an additional 8% of 
deaths were attributed to another type of cancer.60  A portion of this 8% could be attributed to 
distant metastases, or could be due to physicians reporting nonspecific tumor sites on death 
certificates.  The reliability of relative (overall) survival as an outcome measure for cancer 
patients is questionable if life tables don’t accurately portray true mortality in all sub-groups of 
the population.  Reliability of a standard life table could vary by group because of differences in 
the distribution of “other causes” of mortality due to socioeconomic, lifestyle, or genetic risk 
factors. The SEER Program oversamples certain American minority populations (e.g. Alaska 
Natives, Cherokee Nation) to allow for improved cancer incidence and outcome data in these 
relatively small populations.  The NCHS doesn’t publish life tables for Asian Americans or 
American Indians, and racial/ethnic misclassification on death certificates has been found to be 
high within minority populations.53  In cancer research, it is common to focus on overall survival 
rather than cancer-specific survival.  This approach may be most useful when evaluating 
effectiveness of cancer-directed therapies that place patients at risk for non-cancerous adverse 
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events.  However, when evaluating cancer outcomes in populations with older age 
distributions, as is the case with breast, cervical, and colorectal cancer patients, it is 
advantageous to calculate cancer-specific survival because older individuals are also at 
increased risk of death from unrelated causes.  Minority (blacks and non-white Hispanics) 
cancer patients are also more likely than white cancer patients to die of diseases or conditions 
other than cancer.60    
SEER*Stat software allows users to request a cause of death recode.  Deaths within the 
3 patient cohorts are stratified by “cancer causes of death” and “non-cancer causes of death” 
to allow development of a cancer-specific cause of death category in survival analyses.  Thus, at 
the time of failure or censoring, patients are classified as either alive, dead from any malignant 
cancer, or dead from all other causes combined (e.g. diseases of the heart, septicemia, suicide, 
etc.), including in situ, benign, or unknown behavior neoplasms.   
An important early step during the analysis of survival data is the estimation of the 
distribution of patient failure times.  The LIFETEST procedure in the SAS software package can 
be used to compute nonparametric estimates of the cancer-specific survival function using the 
product-limit method.  Kaplan-Meier product limit estimators for survival functions by each 
marital status category are assessed, with differences tested using the log-rank test.  Death 
from any malignant cancer (referred to as cancer-specific death) is considered the event of 
interest, while non-cancer deaths and those who survived through follow-up are censored.  36- 
month cancer-specific survival probabilities are calculated and compared across each marital 
status category.   
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The PHREG procedure in SAS software allows users to perform multiple regression 
analysis of patient survival data based on the semiparametric Cox proportional hazards model.  
Cox proportional hazards analysis can help quantify the effect of predictor variables on hazard 
rates within a population.  In the current study the model is used to quantify the risk of death 
from any cancer during the follow-up period and to estimate the independent association 
between marital status and cancer death for colorectal, female breast, and cervical cancer 
patients.  A backward elimination process with p=0.20 set as cut-off level for covariates is used 
to determine those that may have a meaningful effect on cancer-specific survival among 
colorectal, female breast, and cervical cancer patients.  Tests for violations of the proportional 
hazards assumption are conducted through assessment of Shoenfeld residuals.   
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CHAPTER 4 
RESULTS 
Patient Population Characteristics 
Of the 103 144 colorectal cancer patient records retrieved from the SEER database,      
92 705 had complete demographic and clinical information.  Of the 151 155 female breast 
cancer patients, 141 561 complete records were available; of the 10 267 cervical cancer 
patients, 9 239 complete records were available.  Descriptive tables in this section characterize 
each of the 3 patient populations, stratified by marital status (married, divorced/separated, 
widowed and single).   
Colorectal Cancer Patient Characteristics 
The 92 705 colorectal cancer patients eligible for analysis represent 89.9% of the total 
original cohort downloaded from the 18 participating SEER cancer registries.  Those excluded 
comprise 529 patients listed as unknown race, 6 115 with unknown stage at diagnosis and         
4 754 with unknown marital status.  The total number of missing values for these variables 
amounts to slightly more than the total number of patients excluded because a small number 
of observations (individuals) had missing values for more than one measure.  Colorectal cancer 
patients with unknown marital status were not substantially different from those with known 
marital status with regards to several important variables.  Those with unknown marital status 
were 1.5% more likely to be younger than age 70 years, 2.9% more likely to be female, 0.8% 
more likely to be black, and 3.2% less likely to be diagnosed with distant stage disease.   
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Fifty-two thousand six hundred thirty-one (56.8%) of the patients eligible for analysis were 
married at the time of diagnosis, 8 703 (9.4%) were divorced or separated, 21 234 (22.9%) were 
widowed and 10 137 (10.9%) were single (Table 3).   
Table 3: Demographic and clinical characteristics of colorectal cancer patients, SEER cancer 
registries, 2004-2006 diagnoses, n=92 705 
 
Statistically significant (p<0.0001) differences existed between the 4 marital status categories as 
defined by patient age, sex, race, residential status, and disease stage.  Single colorectal cancer 
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patients were more likely to be in the youngest (50-59 years) age group, while widowed 
patients were far more likely than others to be 80 years of age or older; divorced/separated 
patients were least likely to be 80 years of age or older at diagnosis.  Widowed patients were 
more likely than others to be female, while married patients were predominantly male.  The 
divorced/separated and single populations had approximately equal distributions of males and 
females.  A majority of these colorectal cancer patients was white (82.2%), and whites were 
more likely than other groups to be widowed.  Black patients were approximately twice as likely 
as whites to be divorced/separated or single.  Proportionally, patients classified as ‘other’ race 
were more likely to be married than any other marital status category.  At least 85% of 
colorectal cancer patients in each of the 4 marital status categories lived in metropolitan areas, 
with single patients more likely to be metropolitan and widowed patients most likely to be 
nonmetropolitan.  Married patients were more likely than others to be diagnosed with localized 
disease; divorced/separated and single patients were less likely than those who were married 
or widowed to have localized disease at diagnosis and more likely to have distant stage disease.  
Married patients were least likely among the 4 categories to have distant stage disease at the 
time of diagnosis.   
Female Breast Cancer Patient Characteristics 
The 141 561 female breast cancer patients eligible for analysis comprise 93.7% of the 
total cohort downloaded from the SEER registries.  Those excluded consist of 706 patients listed 
as unknown race, 3 500 with unknown disease stage at diagnosis and 6 298 with unknown 
marital status.  There were no apparent major differences between those included in and 
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excluded from analysis with regards to several important covariates.  Female breast cancer 
patients with unknown marital status were 3.6% less likely to be younger than age 60 years; 
there was no difference in the racial composition of the groups.  Those with unknown marital 
status were 1.3% more likely to be diagnosed with distant stage disease than those who had 
known marital status recorded in the SEER registries. 
Seventy-nine thousand seven hundred twenty-two (56.3%) of the patients included in 
analysis were married at the time of diagnosis, 16 969 (12.0%) were divorced/separated, 27 118 
(19.2%) were widowed and 17 752 (12.5%) were single (Table 4).  Statistically significant 
(p<0.0001) differences existed between the 4 marital status categories by patient age, race, 
residential status, and disease stage.  Proportionally, single female breast cancer patients were 
more likely than others to be in the youngest (40-49 years) age category; widowed patients 
were more likely to be in the oldest (80+ years) age group.  Married and divorced/separated 
patients were more likely than those in other marital status groups to be between 50 and 59 
years of age at diagnosis.  A clear majority of patients in all 4 marital categories was white, with 
those of ‘other’ race most likely to be married and those who were black most likely to be 
divorced/separated or single.  Black patients were more likely to be single (26.3%) than those in 
the other 2 marital status groups, and patients classified as ‘other’ race were more likely to be 
married (65.3%).  Breast cancer patients in all marital categories predominantly lived in areas 
classified as metropolitan, with single patients most likely to reside in metropolitan areas, and 
widowed patients most likely to live in nonmetropolitan areas.   
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Table 4: Demographic and clinical characteristics of female breast cancer patients, SEER cancer 
registries, 2004-2006 diagnoses, n=141 561 
 
Married and widowed patients were more likely than others to have localized breast cancer at 
the time of diagnosis; single patients were least likely to have localized disease.  Single females 
were also more likely than others to have regional or distant stage breast cancer at the time of 
diagnosis; married patients were least likely to be diagnosed with distant stage disease.   
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Cervical Cancer Patient Characteristics 
The 9 239 cervical cancer patients eligible for analysis comprise 90% of the original 
cohort downloaded from the SEER registries.  Those excluded were 82 patients listed as 
unknown race, 523 with unknown stage at diagnosis, and 567 with unknown marital status.  
Cervical cancer patients with unknown marital status did not differ markedly from those with 
known marital status with respect to age (54.62% of those with known marriage and 54.63% of 
those with unknown marriage younger than age 50 years).  Patients with unknown marital 
status were 0.6% less likely to be black, as well as 0.6% less likely to have distant stage cervical 
cancer at the time of diagnosis.   
Four thousand three hundred seventeen (46.7%) of these patients were married at the 
time of diagnosis, 1 343 (14.5%) were separated/divorced, 1 063 (11.5%) were widowed and     
2 516 (27.2%) were single (Table 5).  Statistically significant (p<0.0001) differences existed 
between the 4 marital status categories as defined by patient age, race, residential status, and 
disease stage.  Proportionally, single cervical cancer patients were more likely than those in 
other marital status groups to be younger than 40 years of age.  Widowed patients were the 
most likely of the 4 marital status groups to be age 70 years or older at the time of diagnosis.  
Married patients were more likely than others to be between 40 and 49 years of age at 
diagnosis.  As with the colorectal and female breast cancer cohorts, a majority of cervical 
cancer patients in this population was white.  Black patients were more likely to be single 
(46.0%), while white patients were more likely than others to be divorced/separated (15.6%).  
Those patients classified as ‘other’ race (50.1%) were more likely than others to be married.   
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Table 5: Demographic and clinical characteristics of cervical cancer patients, SEER cancer 
registries, 2004-2006 diagnoses, n=9 239 
 
Most cervical cancer patients lived in metropolitan areas.  Proportionally, single patients were 
more likely to live in metropolitan areas, and widowed were more likely to live in 
nonmetropolitan areas.  Married patients were more likely than others to have localized 
disease at diagnosis and were least likely to have distant stage disease.  Conversely, widowed 
patients were least likely to have localized disease at diagnosis and more likely than those in 
the other 3 marital status groups to be diagnosed with regional or distant disease.         
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Marital Status and Advanced Tumor Stage at Diagnosis 
The proportional odds assumption was not met with these data, so the dependent 
variable tumor stage at diagnosis could not be treated as ordinal.  Table 6 presents results of 
the baseline category logit model assessing marital status and other factors’ relationships with 
stage of colorectal cancer at the time of diagnosis.  The 2 results columns (labeled ‘Regional’ 
and ‘Distant’) contain odds ratios comparing patients in categories of the primary predictor and 
each covariate to a category-specific baseline referent with respect to their likelihood of being 
diagnosed with the later stages of either regional or distant as compared to the basline 
outcome of localized cancer.  Ecological variables serving as proxies for educational level and 
income did not meaningfully improve the model, and were not included as covariates in the 
final model.   
Patients in each of the 3 ‘non-married’ categories (divorced/separated, widowed, single) 
were significantly more likely to have regional (vs. localized) and distant (vs. localized) stage 
colorectal cancer at the time of diagnosis compared to married patients (p-value range: 
<0.0001-0.0007).  Divorced/separated patients had the highest likelihood of later stage disease 
relative to married patients for both stage comparisons (OR=1.11, 95% CI 1.05-1.17 for regional 
vs. localized and OR=1.36, 95% CI 1.28-1.44 for distant vs. localized).  Females were slightly 
more likely than males to have regional stage disease at diagnosis (OR=1.06, 95% CI 1.03-1.09), 
but there was no discernible female vs. male difference for the distant vs. localized stage 
disease comparison (p=0.0626).   
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Table 6: Baseline category logit analysis of marital status and other factors predicting colorectal 
cancer stage at diagnosis, SEER cancer registries, 2004-2006 diagnoses, n=92 705 
 
There was no apparent trend in effect size change with advancing patient age (ORs 0.99, 0.94 
and 0.95 for 60-69, 70-79, and 80 years of age and older, respectively) for the regional vs. 
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localized comparison, while for the distant vs. localized comparison progressively higher age 
groups seemed to enjoy modestly larger protective effects (OR=0.94, 95% CI 0.89-0.99, 
OR=0.79, 95% CI 0.75-0.84, and OR=0.78, 95 % CI 0.73-0.82 for 60-69, 70-79, and 80 years of 
age and older, respectively).  There was no significant difference between black and white 
patients for the regional vs. localized comparison (p=0.6007) or between those classified as 
‘other’ race and whites for the distant vs. localized comparison (p=0.9477).  Those of ‘other’ 
race were slightly more likely than whites to have regional vs. localized disease (OR=1.09, 95% 
CI 1.03-1.15), and blacks were 25% more likely than whites to have distant vs. localized stage 
colorectal cancer at diagnosis (OR=1.25, 95% CI 1.18-1.32).  Residing in a nonmetropolitan area 
seemed to be marginally protective, but the odds ratios for these measures were close to null 
for both regional vs. localized and distant vs. localized comparisons (0.93, 95% CI 0.89-0.97 and 
OR=0.94, 95% CI 0.90-0.99 respectively).  The variable for patient sex appeared to modify the 
relationship between marital status and stage (p=0.0003), and the data were subsequently 
stratified (See Appendix A).  After stratifying by sex, divorced/separated, widowed, and single 
males were more likely to be diagnosed with distant vs. localized disease than females, with the 
disparity in effect sizes most pronounced among the divorced/separated (OR 1.49, 95% CI 1.37-
1.62 in males compared to OR 1.22, 95% CI 1.12-1.33 in females) and single patients (OR 1.46, 
95% CI 1.36-1.58 in males compare to OR 1.17, 95% CI 1.07-1.27 in females).  It would appear 
that among colorectal cancer patients, the protective association between marriage and 
disease stage at diagnosis is stronger in men than women.       
Table 7 presents results of the baseline category logit model characterizing the 
association of marital status and other factors with later stage breast cancer at diagnosis.   
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Table 7: Baseline category logit analysis of marital status and other factors predicting female 
breast cancer statge at diagnosis, SEER cancer registries, 2004-2006 diagnoses, n=141 561 
 
Ecological variables for education, income, and screening mammography did not 
meaningfully improve the model and were excluded from the final version.  Residential status 
was also excluded as a covariate during model development due in part to a low Wald χ2 value 
noted during analysis of effects.  The variable exceeded the 0.2 significance level specified for 
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removal of potential covariates during backward model selection.  Marital status, age, and race 
were included as predictor variables in the final model.   
Women in the divorced/separated, widowed, and single categories were significantly 
more likely than those in the married category to have regional vs. localized breast cancer at 
the time of diagnosis, with the effect size more considerable across these same categories for 
the distant vs. localized disease comparison.  Single women were most likely to be diagnosed 
with tumors at the lastest stage; they had a 77% higher likelihood of distant vs. localized 
disease than those who were married (OR=1.77, 95% CI 1.66-1.99).  Advanced age had a 
progressively larger protective effect for the regional vs. localized disease comparison, while 
the 4 older (compared to the referrent) age groups in the distant vs. localized comparison 
demonstrated no uniform trend, with 2 of the outcome measures (for ages 60-69 and 70-79 
years) failing to reach statistical significance.  Black patients had higher likelihood than whites 
of regional vs. localized (OR=1.33, 95% CI 1.28-1.38) and distant vs. localized disease (OR=1.83, 
1.72-1.95) at diagnosis, while those classified as ‘other’ race were not significantly different 
from whites at either level of comparison.  An interaction term for race by marital status was 
marginally significant (p=0.0430), and data were stratified by race (See Appendix B).  Once 
stratified by race, the only substantial departures from effect sizes observed in the full model 
were among divorced/separated and single women classified as ‘other’ race.  These women 
had more than twice the likelihood of distant vs. localized disease at diagnosis compared to 
married peers (OR=2.05, 95% CI 1.54-2.73 and OR=2.29, 95% CI 1.81-2.91 for 
divorced/separated and single, respectively).  Smaller sample sizes and less precise estimates 
within this stratification scheme, evidenced by wider confidence intervals, could play a role in 
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these observed differences, although a majority of the effect size estimates for white and 
‘other’ race patients are statistically significant.                 
Table 8 presents results of the baseline category logit model describing the association 
of marital status and age with later stage cervical cancer at the time of diagnosis.   
Table 8: Baseline category logit analysis of marital status and other factors predicting cervical 
cancer stage at diagnosis, SEER cancer registries, 2004-2006 diagnoses, n=9 239 
 
 
65 
 
Ecological variables for education, income, and Pap test prevalence, as well as individual-level 
variables for race and residential status did not meaningfully improve the model and were 
excluded either prior to full model development or during a backward elimination process.  
Women in each of the 3 non-married categories were more likely than those who were married 
to have regional vs. localized cervical cancer at diagnosis, with divorced/separated women 
having the greatest increased likelihood (OR=1.49, 95% CI 1.31-1.71).  The same is true for the 
distant vs. localized comparison, except that single women had the highest likelihood of distant 
disease relative to the married (OR=1.68, 95% CI 1.42-1.98).  While controlling for patient 
marital status, there was a distinct age gradient, with elevated likelihoods of later stage disease 
relative to the youngest age group for both baseline stage comparisons.  The adverse 
association with advanced age was more pronounced within each categorical stratum in the 
distant vs. localized compared to the regional vs. localized column.  Those who were 70 years of 
age or older had more than 4 times (OR=4.19, 95% CI 3.51-5.00) higher likelihood of being 
diagnosed with regional vs. localized cervical cancer than those younger than age 40 years, 
while the oldest patients were nearly 6 times more likely than the youngest (OR=5.78, 95% CI 
4.39-7.61) to have distant vs. localized disease at the time of diagnosis.        
Marital Status and Cancer-specific Survival 
Colorectal Cancer and Survival 
Figure 5 shows cancer-specific survival probability curves comparing colorectal cancer 
patient survival by marital status category.  Unadjusted Kaplan-Meier survival analysis 
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demonstrated that throughout follow-up, married patients had better cancer-specific survival 
than those who were divorced/separated, single, and widowed.   
 
Figure 5: Kaplan-Meier plot, colorectal cancer patient survival, in months, stratified by marital 
status, SEER cancer registries, 2004-2006 diagnoses 
The log-rank test for equality across marital status strata was statistically significant (p<0.0001).  
Of the 33 547 patients who died of any cancer during follow-up, 16 557 (49.4%) were married,   
3 488 (10.4%) were divorced/separated, 3 986 (11.9%) were single, and 9 516 (28.4%) were 
widowed.  64 842 patients were right censored (survived or died of a non-cancer cause), of 
whom 38 285 (59.0%) were married, 5 809 (9.0%) were divorced/separated, 6 809 (10.5%) were 
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single, and 13 939 (21.5%) were widowed.  At 36 months, the longest uniform follow-up time 
for all individuals, cancer-specific survival was 73.3% for married, 65.4% for divorced/separated, 
65.2% for single, and 59.7% for widowed patients.   
Among patients diagnosed with invasive colorectal cancer, being married at the time of 
diagnosis was associated with superior cancer-specific survival during the follow-up period, 
independent of sex, age, race, and disease stage (Table 9).  Ecological variables for education 
level and household income, as well as a variable characterizing patient residential 
(metropolitan vs. nonmetropolitan) status did not meaningfully improve the multiple regression 
model, and were excluded from the final version.  Divorced/separated and single patients had 
approximately 30% higher risk of death during follow-up (Hazard Ratio=1.29, 95% CI 1.24-1.34 
and HR=1.30, 95% CI 1.25-1.35, respectively) than those who were married at the time of 
diagnosis; widowed patients had 24% higher risk of death during follow-up than married 
patients (HR=1.24, 95% CI 1.20-1.28).  Controlling for other relevant factors, females had a 
lower risk of death during follow-up (HR=0.88, 95% CI 0.85-0.90), and advancing age was 
consistently associated with increased risk of cancer-specific death, with a nearly 3-fold 
increase in risk among those who were 80 years of age or older compared to those in the 
youngest age group (HR=2.70, 95% CI 2.60-2.80).  Black colorectal cancer patients had a 20% 
higher risk of death than whites at any point during follow-up, while being classified as ‘other’ 
race was associated with slightly better survival.  Having regional stage colorectal cancer at 
diagnosis was associated with more than 2-fold higher risk compared to those with localized 
disease (HR=2.31, 95% CI 2.24-2.39), while those with distant stage disease were nearly 13.5 
times more likely to die of any cancer during the follow-up period (HR=13.43, 95% CI 13.01-
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13.86).  Patient sex modified the association between marital status and cancer-specific 
survival, and data were stratified by sex to assess the effect this interaction may have on hazard 
ratios in the full model (See Appendix C).   
Table 9: Multivariate Cox proportional hazards model for marital status and other variables 
predicting death from any cancer among colorectal cancer patients, SEER cancer registries, 
2004-2006 diagnoses  
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Although a term included in the model to assess for interaction between patient sex and 
marital status was statistically significant (p=0.0045), following stratification, the changes in 
hazard ratios across marital status categories were relatively minor.  However, it appears that 
being married was more protective among male colorectal cancer patients than among 
females, as hazard ratios for divorced/separated, widowed, and single patient groups were 1.34 
(95% CI 1.27-1.42), 1.26 (95% CI 1.20-1.33), and 1.37 (95% CI 1.31-1.44) respectively, all 
modestly higher than those observed among female counterparts.  This aside, it’s clear that 
while controlling for relevant factors available in the SEER registry database, colorectal cancer 
patients in each of the 3 ‘non-married’ categories were at significantly higher risk of cancer-
specific death during the years immediately following their diagnoses.            
Breast Cancer and Survival 
Unadjusted Kaplan-Meier survival curves showed married breast cancer patients with 
the highest survival probability, divorced/separated and single with nearly identical curves and 
widowed patients with the lowest cancer-specific survival probability (Figure 6). The log-rank 
test for equality across strata was statistically significant (p<0.0001).  Of the 18 320 female 
breast cancer patients who died of any cancer during follow-up, 7 651 (41.8%) were married,    
2 486 (13.6%) were separated/divorced, 2 756 (15.0%) were single, and 5 427 (29.6%) were 
widowed.  Of the 126 537 patients who were censored, 73 171 (57.8%) were married, 14 876 
(11.8%) were separated/divorced, 15 466 (12.2%) were single, and 23 024 (18.2%) were 
widowed.  After 36 months of follow-up, cancer-specific survival was 93.1% for married, 88.8% 
for divorced/separated, 87.7% for single, and 83.6% for widowed patients.     
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Figure 6: Kaplan-Meier plot, female breast cancer patient survival, in months, stratified by 
marital status, SEER cancer registries, 2004-2006 diagnoses 
Married females diagnosed with invasive breast cancer had lower risk of death than 
those in all 3 non-married categories, independent of age, race, and tumor stage at diagnosis 
(Table 10).  Ecological variables serving as proxies for patient household income, education and 
mammography screening prevalence, as well as an individual-level variable describing 
residential status, didn’t improve the model and were excluded from the final version.   
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Table 10: Multivariate Cox proportional hazards model for marital status and other variables 
predicting death from any cancer among female breast cancer patients, SEER cancer registries, 
2004-2006 diagnoses  
 
The elevated risk of cancer-specific death was nearly uniform across the divorced/separated, 
widowed, and single groups with hazard ratios of 1.29 (95% CI 1.23-1.36), 1.31 (95% CI 1.26-
1.37), and 1.33 (95% CI 1.27-1.39) respectively.  Risk of cancer-specific death was progressively 
higher with increasing age, with those patients age 80 years and older having nearly 3 times the 
risk of those between the ages of 40 and 49 years (HR=2.94, 95% CI 2.77-3.12).  As was the case 
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in colorectal cancer patients, but within this cohort to a greater extent, black female breast 
cancer patients had higher risk of cancer-specific death (HR=1.66, 95% CI 1.59-1.73 compared 
to whites), while those classified as ‘other’ race enjoyed a small protective association 
(HR=0.88, 95% CI 0.82-0.95).  Once again, disease stage was inversely proportional to cancer-
specific survival during follow-up, with nearly 3-fold and more than 20-fold higher risk of death 
from any cancer among those with regional and distant stage breast cancer respectively 
(HR=2.90, 95% CI 2.80-3.02, HR=20.69, 95% CI 19.90-21.50).  Upon inclusion of a model term 
assessing interaction, it appeared that the variable race modified the association between 
patient marital status and cancer-specific survival during follow-up (p=0.0002).  Data were 
stratified by race and the new models were interpreted (See Appendix D).  Effect sizes across 
each of the 3 non-married categories remained essentially unchanged among whites (HR=1.30, 
95% CI 1.23-1.37, HR=1.31, 95% CI 1.25-1.37, and HR=1.27, 95% CI 1.20-1.34 for 
divorced/separated, widowed, and single breast cancer patients respectively).  Among the black 
female breast cancer patient population, the protective effect was slightly lower among the 
divorced/separated and widowed patients relative to the married (HR=1.20, 95% CI 1.07-1.35 
and HR=1.28, 95% CI 1.14-1.45 respectively), while risk of death among single patients was 
modestly higher relative to the entire population (HR=1.36, 95% CI 1.23-1.50 in blacks 
compared to HR=1.33, 1.27-1.39 in the full model).  The protective association with marriage 
appears to be most pronounced among those classified as ‘other’ race.  Those who were 
divorced/separated had a corresponding hazard ratio of 1.64 (95% CI 1.32-2.02) compared to 
their married counterparts, a marked departure from that of 1.29 (95% CI 1.23-1.36) observed 
in the full population.  Single patients in the ‘other’ race category (HR=1.55, 95% CI 1.28-1.87) 
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also experienced higher risk relative to married patients compared to the same measure in the 
full model (HR=1.33, 95% CI=1.27-1.39).  For effect size estimates in the models stratified by 
race, the confidence intervals were wider and the corresponding p-values were larger, although 
each hazard ratio for the non-married categories across all 3 race strata remained statistically 
significant.                
Cervical Cancer and Survival 
Among cervical cancer patients, unadjusted Kaplan-Meier survival analysis showed clear 
differences in cancer-specific survival probabilities between the 4 marital status categories, 
with married patients having the best survival, followed by single, divorced/separated, and 
widowed patients respectively (Figure 7). The log-rank test for equality across strata was 
significant (p<0.0001).  Of the 2 739 cervical cancer patients who died of any malignant cancer 
during follow-up, 1 021 (37.3%) were married, 462 (16.9%) were separated/divorced, 727 
(26.5%) were single, and 529 (19.3%) were widowed.  Of the 6 960 who were censored, 3 445 
(50.0%) were married, 960 (13.8%) were separated/divorced, 1 916 (27.5%) were single, and 
639 (9.2%) were widowed.  After 36 months of post-diagnosis follow-up, cancer-specific 
survival in this cohort was 78.8% among married, 69.1% among separated/divorced, 73.3% 
among single, and 54.4% among widowed patients.    
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Figure 7: Kaplan-Meier plot, cervical cancer patient survival, in months, stratified by marital 
status, SEER cancer registries, 2004-2006 diagnoses 
Among women diagnosed with invasive cervical cancer, being married at the time of 
diagnosis was associated with lower risk of death from any cancer during follow-up compared 
to those who were divorced/separated (HR=1.21, 95% CI 1.07-1.35), widowed (HR=1.32, 95% CI 
1.16-1.50), and single (HR=1.19, 95% CI 1.07-1.31) (Table 11).  Ecological variables substituted 
as proxies for patient household income, education and Pap testing prevalence did not 
meaningfully improve the model and weren’t included in the final version.   
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Table 11: Multivariate Cox proportional hazards model for marital status and other variables 
predicting death from any cancer among cervical cancer patients, SEER cancer registries, 2004-
2006 diagnoses  
 
There was no significant difference in risk of death among those age 40 and 49 years compared 
to those younger than age 40 years (p=0.4123), but patients who were 50-59 (HR=1.24, 95% CI 
1.09-1.41), 60-69 (HR=1.33. 95% CI 1.15-1.53), and older than age 70 years (HR=2.30, 95% CI 
1.99-2.66) had increased risk of death compared to the youngest patients.  Black patients with 
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cervical cancer in this cohort had a higher risk of death from any cancer than whites (HR=1.27, 
95% CI 1.14-1.41); there was no statistically significant difference between those classified as 
‘other’ race and whites (p=0.1027).  Women who lived outside metropolitan areas had slightly 
higher risk of death during follow-up (HR=1.16, 95% CI 1.03-1.30).  As was the case with 
colorectal and female breast cancer patients, cervical cancer patients with regional (HR=4.98, 
95% CI 4.42-5.60) and distant stage disease (HR=19.03, 95% CI 16.74-21.65) had substantially 
higher risk of death from any cancer during the follow-up period.    
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CHAPTER 5 
DISCUSSION 
Primary Findings 
In this population-based study, married patients with colorectal, breast, and cervical 
cancer experienced better cancer-related outcomes than those who weren’t married.  These 
findings have certain limitations, but this much is clear: 1) married adults with colorectal, 
breast, and cervical cancer (all of which can be detected early with routine screening) were 
diagnosed at an earlier disease stage than their non-married counterparts, and 2) even after 
controlling for stage and important demographic factors, married patients experienced better 
all-cancer survival than those who were divorced/separated, widowed, or single.   
Within the 3 non-married groups, differences existed in cancer stage distribution and 
survival, but the disparity between the 2 broader groups (married and non-married) was 
remarkably consistent across each of the 3 anatomic cancer sites and multiple levels of analysis.  
Even with limited information about the screening and treatment behaviors of the patients in 
these 3 cohorts, unmarried adults are a subset of the population that may stand to benefit from 
targeted prevention or care initiatives throughout the natural course of preventable and/or 
detectable cancers.  Given the consistently protective association between marriage and 
superior cancer outcomes observed in this study, researchers focusing on patients with 1 of 
these 3 cancers should consider marital status as a meaningful determinant of stage at 
diagnosis and cancer-specific survival.  In the meantime, additional research examining the 
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mechanisms underlying the association between marriage and cancer-specific survival in 
patients diagnosed with these 3 cancers is important.      
Distant Stage Cancer at Diagnosis 
In looking at colorectal and female breast cancer stage at diagnosis outcomes, the 
protective association among those who were married compared to that of patients in the 3 
non-married groups was consistently stronger for the distant vs. localized than for the regional 
vs. localized stage comparisons (Tables 6 and 7).  The same was true in the stratified analyses 
(Appendices A and B), with the protective association especially pronounced among the male 
colorectal cancer patients.  This was not the case among cervical cancer patients, with the 
exception of those in the single (never married) group (Table 8).  It is possible that differences 
in social network support may explain some of variation in the associations.  For example, 
perhaps less adherence (e.g. lower prevalence or frequency of screening) to early detection 
guidance for colorectal and breast cancer in the 3 non-married groups could result in discovery 
at a later stage disease by virtue of clinical symptomatology.   The result would be a stronger net 
protective effect of marriage through its influence on the use of clinical preventive services.  
The largest difference observed in the regional/distant vs. localized comparisons was among 
single patients.  This was true for all 3 cancer sites (and was the only of the non-married 
categories to have a stronger distant vs. localized comparison within the cervical cancer 
cohort).  Those who have never been married may be less likely to have some of the residual 
familial support network (e.g. adult children, or lasting friendships developed with or through 
an ex-spouse, etc.) enjoyed by those in the divorced/separated and widowed groups.  Smaller 
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support networks could result in lower overall levels of external encouragement to adhere to 
recommended early detection schedules for these cancers.  In cancers that can potentially be 
detected early, stage at diagnosis data are often evaluated within the context of population 
screening rates broken down by variable(s) of interest.  According to the most recent Centers 
for Disease Control and Prevention (CDC) data linked to USPSTF guidelines, non-married 
(divorced/separated, widowed, and single) individuals are more likely to fail to meet guidelines 
for colorectal, breast, and cervical cancer screening compared to those who are currently 
married.61  In 2010, 62.9% of married adults were up-to-date with USPSTF guidelines for 
colorectal cancer screening, compared to 54.1% of divorced/separated, 54.7% of widowed, and 
49.6% of single men and women.  Similar differences were reported among women screening 
for breast and cervical cancers.  Greater than 76% of married women were meeting USPSTF 
guidelines for breast cancer screening in 2010, compared to 63.7% of divorced/separated, 
71.8% of widowed, and 66.1% of single women.  Nearly 86% of married women were current 
with USPSTF guidance for cervical cancer guidance during the same time period, compared to 
81.3% of divorced/separated, 78.0% of widowed, and 77.2% of single women.61  These CDC 
data were derived from a nationally population-based representative sample from the SEER 
registries although the data did not incorporate the entire U.S. population.  With this in mind, 
the marked differences in national cancer screening rates between married and non-married 
individuals are still consistent with the findings in the current study that non-married colorectal, 
breast, and cervical cancer patients tend to be diagnosed with later stage disease compared to 
married counterparts.          
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Interestingly, among breast cancer patients, advancing age was increasingly protective 
in older age women, who had a lower likelihood of regional compared to localized disease.  
There was essentially no age trend in associations for the distant vs. localized comparison.  This 
was not the case among cervical cancer patients, where increased age was a risk factor for later 
tumor stage at diagnosis, with an increase in likelihood of both regional and distant stage 
disease from the youngest to the oldest age groups.  One potential explanation for this finding 
among breast cancer patients could be that the younger women in this cohort may be more 
likely than older women to have genetic mutations predisposing them to more aggressive types 
of breast cancer than their older counterparts.  Research has found that younger women with 
breast cancer are more frequently diagnosed with non-localized disease and their tumors may 
be more likely to show characteristics unfavorable to prognosis.62  However, this hypothesis is 
complicated by the absence of the same trend among those diagnosed with distant stage 
disease, but it’s possible that breast cancers associated with certain mutations in younger 
women may be more frequently discovered (through mammography or clinical exam) at the 
regional stage. 
Among colorectal cancer patients, a similar, though less pronounced trend was 
observed with advancing age in the distant vs. localized stage comparison although the same 
association was not seen for age and regional vs. localized disease, which was null or close to 
null.  However, for the distant vs. localized comparison, women 70 years of age or older had 
greater than 20% lower likelihood of distant stage disease than those in the youngest age group 
(OR=0.79, 95% CI 0.75-0.84 and OR=0.78, 95% CI=0.73-0.82 for 70-79 year-olds and 80+ year-
olds respectively).  One potential explanation for this finding may be that older individuals who 
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perceive that they are at risk for colorectal cancer based on personal history or familial risk 
factors are more likely to pursue gold-standard screening, such as colonoscopy, to catch this 
disease early.  Research has shown that younger individuals are more likely to be diagnosed 
with less differentiated and later stage colorectal cancer, which may be partially attributed to 
higher rates of screening in older age groups.5   Colonoscopies are expensive procedures, but 
Medicare began covering them for average-risk beneficiaries in 2001, whereas previously 
coverage had been limited to those who were deemed high-risk.63  Removal of a substantial 
cost barrier, and the subsequent effect on screening behavior, could have increased the 
likelihood that those old enough to qualify for this benefit generally detect the disease at an 
earlier stage.  It is unclear what could be influencing the difference in the protective 
associations of age for the regional and distant stage comparisons, but it may be worth 
examining differences in primary tumor site and histology to see if variations in these factors 
are disproportionately associated with either younger or older patients.   
Black patients had had 25% higher likelihood of distant vs. localized stage disease at 
diagnosis compared to whites and those classified as ‘other’ race.  In part because of historically 
high rates of disease and death, colorectal cancer awareness has been heavily promoted within 
African American communities in the United States in recent years; research published just 
prior to the period when patients in this cohort were diagnosed found that blacks were actually 
more likely to be current with colorectal cancer screening guidelines than whites.64  However, 
blacks are still more likely than whites to be diagnosed with advanced stage colorectal cancer, 
but disparities in anatomic sub-site (e.g. proximal vs. distal disease) of diagnosis and potential 
differences in tumor aggressiveness by race render it difficult to disentangle truly independent 
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effects of screening, race, genetics, and exposures on differential outcomes in stage at 
diagnosis.65  Black female breast cancer patients were more likely than those of other races to 
have regional and distant stage disease at the time of diagnosis.  Researchers have long held 
that black women are more likely than whites to be diagnosed with late stage breast cancer.66  
Factors beyond racial differences in mammography screening rates likely influence this 
disparity; some of the most notable possibilities include socioeconomic status, lifestyle factors, 
and biologic tumor characteristics.67                  
Survival Following Cancer Diagnosis 
In unadjusted analysis, widowed colorectal cancer patients experienced the lowest 3-
year survival of all the marital status categories, but single patients had the largest 
corresponding hazard ratio in the adjusted Cox proportional hazards model (Table 9).  It is 
difficult to make direct comparisons between the findings of our study and the results from 
past studies. In prior studies researchers only considered colon cancer,38,43 conducted their 
work in foreign countries with considerably different health care systems,42 or published their 
findings decades ago.41  Also, there were differences in how the outcome ‘event’ of interest 
(e.g. death from one cancer, death from any cancer, death from any cause, etc.) was defined.  
These variations could limit the comparability of the effect sizes determined by using survival 
analyses.  Keeping these limitations in mind, it is valuable to compare the findings of the 
current study with those of past related research studies in order to consider consistencies, 
discrepancies, and potential strategies to improve the validity of this type of outcomes 
research.   
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Within the United States, colon cancer is far more prevalent than rectal cancer, and the 
hazard ratio for colorectal cancer patients who are single (HR=1.30, 95% CI 1.25-1.35) was 
slightly larger than that observed in colon cancer patients in Lai’s study (HR=1.23, 95% CI 1.18-
1.29) although the association was in the same direction and of similar magnitude.43  
Interestingly, the patients in the other non-married categories (divorced, separated, widowed) 
in Lai’s study had hazard ratios closer to the referent (married patients) than did non-married 
patients in the cohort analyzed for the current study.  The difference between risk of death in 
other non-married patient categories in Lai’s cohort (HR range: 1.11-1.15) and the same 
categories in the current study (HR range 1.24-1.29) is meaningful when one considers the 
number of total cases of colorectal cancer (more than 133 000 diagnosed in the United States 
each year).4  The true difference in risk of death by marital status may be slightly larger in rectal 
cancer patients than colon cancer patients, which could mean Lai’s technique of treating the 
two as distinct tumors during analysis may mask some of the actual risk present in the broader 
patient population, but this would be difficult to determine without further stratification and 
analysis.  Results from Goodwin’s study, however, do not support the idea that marital status is 
more protective among rectal compared to colon cancer patients, although the methods are 
not entirely analogous.  Their results do not display effect sizes for specific tumors by non-
married subgroups, but rather present them as unmarried vs. married.  These do show higher 
risk of nonlocal disease and failure to receive treatment among unmarried rectal compared to 
colon cancer patients, but the relative risk of dying is lower in unmarried rectal cancer patients 
after controlling for disease stage and receipt of treatment (RR=0.97, 95% CI 0.84-1.28 in rectal 
cancer patients, RR=1.27, 95% CI 1.11-1.45 in colon cancer patients).41  The current study does 
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not consider receipt of definitive treatment which would have been difficult to define across 
each of the 3 tumor types and multiple years.  On the other hand, Goodwin et al controlled for 
this factor which could influence their final effect size estimations.   
Wang et al used single patients as the referent in their Cox proportional hazards model 
and found that married patients were 14% less likely (HR 0.86, 95% CI 0.82-0.90) to die from 
cancer than those who were single.  They used a similar definition for the event of interest 
(death from any cancer), which should enhance the comparability of results.  However, only 
colon cancer patients were considered, and they were also able to control for receipt of cancer-
directed surgery.38  Other researchers studying cancer-specific survival have suggested that 
never-married (single) men’s higher likelihood of substance abuse and risky behaviors may 
result in an increased prevalence of comorbidities relative to women, which could negatively 
influence health status as well as disease progression.39  After stratifying by sex, the 
proportional hazards model in Appendix C provided some support for this hypothesis, with an 
elevated hazard ratio in single men (relative to other non-married groups) while the hazard 
ratio in women was essentially identical across the 3 non-married groups.  Methodological 
differences notwithstanding, the existence of a clear protective association between marriage 
and survival after colorectal cancer diagnosis, even after controlling for tumor stage, is 
consistent between the current study and those done in the past.  The effect of ‘receipt of 
definitive surgery’ as a potential confounder is not entirely known, but results of the current 
study suggest the effect of marriage on survival may be slightly more pronounced than has 
been previously reported, further emphasizing the importance of expanded research into the 
behavioral or immunologic mechanisms influencing this phenomenon. 
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As was the case with colorectal cancer patients, widowed female breast cancer patients 
experienced the lowest 3-year cancer-specific survival during unadjusted analysis, but those 
who were single had the largest corresponding hazard ratio in proportional hazards analysis 
(HR=1.33, 95% CI 1.27-1.39), during which age, race, and cancer stage were controlled.  Effect 
sizes across the 3 non-married categories (divorced/separated, widowed, single) were nearly 
identical (HR range: 1.29-1.33), potentially lending support to a hypothesis that the 
mechanisms influencing marriage’s association with survival in breast cancer patients may 
equally induce a protective effect regardless of the particular way an individual enters (or 
remains in) the non-married state.  Among those classified as ‘other’ race, divorced/separated, 
and single patients, but not those who were reported as widowed, had markedly higher risk of 
cancer-specific death during follow-up than that which was observed in the full model.  The 
reason widowed patients did not also experience higher risk of death during follow-up is 
unclear, but it could mean that among certain racial minorities, widowed individuals are more 
likely to have either the self-efficacy and/or support network necessary to make it more likely 
that they will pursue aggressive cancer-directed treatment.  Age was controlled for in the 
regression models, so it is unlikely that differences in age distribution between those who were 
widowed and others had any influence on the relatively superior outcomes of the widowed 
patients under these specific circumstances. 
During unadjusted analysis, widowed cervical cancer patients had substantially lower 3-
year cancer-specific survival than those who were married (54.4% vs. 78.8% respectively), the 
largest survival difference between married patients and a non-married group for any of the 3 
cohorts.  In Cox proportional hazards analysis, widowed patients retained the highest risk of 
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cancer-specific death during follow-up even after adjusting for confounders; this was the only 
instance among the 3 cohorts when the group with the poorest survival during unadjusted 
analysis also had the largest corresponding hazard ratio in the Cox model.  Research has shown 
that widowed women are less likely than married, cohabitating, divorced/separated, and single 
women to report being up-to-date with Pap testing.29  Controlling for disease stage likely 
accounts for some of the survival difference attributable to disparities in cervical cancer 
screening; receipt of definitive treatment was not controlled for in the current study.  However, 
if widowed women are less likely to stay current with appropriate preventive guidelines, they 
may also be less likely to seek and receive cervical cancer treatment, or they may not address 
their disease as aggressively as those in other marital status categories.  In a study of factors 
associated with untreated cervical cancer in the United States, patients who were unmarried 
and older were less likely to receive any treatment following their diagnosis.68  Other 
researchers have found that older patients were more likely to eschew treatment altogether or 
choose less aggressive treatment options.69  While the current study controlled for age, it’s 
clear that widowed patients have the oldest age distribution (Table 5), with more than 55% 
falling into the 70 years of age or older category.  If old age is indeed associated with a lower 
likelihood of receiving appropriate cancer-directed treatment, then widowed patients in this 
SEER cohort may not be receiving the level of post-diagnostic care enjoyed by those in other 
marital status categories.  The distinct age/hazard gradient observed in Table 11 suggests that 
even while controlling for other factors, advanced age is still associated with a lower likelihood 
of survival following cervical cancer diagnosis.  While on the surface this may not appear to be a 
very surprising finding, Coker et al suggest that there is still controversy over whether age is 
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associated with survival after controlling for relevant confounders.69  The protective effect of 
younger age, even after controlling for stage and race, was consistent with the general findings 
reported by Coker, although they also controlled for receipt of cancer-directed treatment. 
The observational, retrospective nature of the current study prohibits definitive 
conclusions on whether the differences in survival between married and non-married patients 
were a result of patient health before the development of cancer, patient post-diagnosis 
behavior related to clinical decisions and familial interactions, immunologic differences, or 
some combination of these factors.  A logical next step to begin addressing this question could 
be to define ‘best practices’ in cancer-directed treatment during the time period in which these 
patients were diagnosed and followed (2004 through 2009), and determine whether being 
married influenced the likelihood of patients in the 3 tumor cohorts receiving appropriate 
therapy.            
Proponents of the selection effect commonly emphasize that healthier individuals may 
be more fit (and desirable) for marriage in the first place, which could account for some of the 
observed survival advantage among married patients.38  Kaplan et al suggested that lower 
survival in the never married compared to the divorced/separated and widowed may provide 
evidence supporting the presence of this effect, because never entering marriage may increase 
the likelihood for more severe social isolation and reduced social connectedness.47  In the 
current study, the never married (single) patients had lower adjusted survival than the 
divorced/separated and widowed for 2 of the 3 cancer patient cohorts (colorectal and female 
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breast), although the differences in effect sizes were not very pronounced.  Single patients had 
the longest adjusted survival of the 3 non-married groups in the cervical cancer cohort.   
Further consideration raises an interesting prospect, however, in that it’s clear that the 
selection effect and the social causation effect, 2 of the leading theories proposed to explain 
the protective health effect of marriage, usually cannot be totally disentangled.  While the 
selection effect may limit the marriage prospects of less healthy individuals (resulting in fewer 
‘unfit’ individuals getting married), the relative deficiency of social networks in those left out of 
marriage is likely to exacerbate the disparity in health outcomes between the 2 groups.  It 
seems likely that the presence or absence of one effect in combination with the other could 
modify the cumulative impact on health incomes.  If there does prove to be a larger negative 
effect on cancer survival in never-married individuals, then it could be worthwhile to 
investigate the potential mediating factors, because recent research on all combined types in a 
European cancer patient population suggests that the excess mortality in single compared to 
married individuals has increased in recent years, especially among men, while the excess 
mortality observed in divorced/separated men and women has remained stable.70  While the 
aforementioned research was conducted in a country with universal access to healthcare, as 
well as different societal norms for marriage, increasing health outcome disparities between 
the single and the previously-married could be an early indication of reduced society-level 
cohesion, which may leave single individuals especially vulnerable due to limited social support 
networks.  The current study does not compare survival estimates across time, so from these 
data it is impossible to know whether a similar trend of excess never-married mortality is 
occurring in patients diagnosed with these cancers in the United States. 
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The findings in the current study that non-married cancer patients were diagnosed at 
later disease stage, and subsequently (while controlling for age) had poorer survival than 
married counterparts, fits with components of the social causation theory, although we can’t 
know how much of the effect sizes are attributable to this factor.  Enhanced social networks 
present during married life may positively influence decisions related to physical activity, diet, 
tobacco and alcohol use, and health-seeking behaviors, all of which influence tumor 
development and/or cancer prognosis.71  Children from a current (or previous) marriage may 
also play a positive role in helping elders navigate the health care system.70  
Others who have researched social support networks’ potential to serve as ‘stress 
buffers’ through the effects of natural killer cells (cytotoxic cells of the immune system that 
respond to tumor growth) have suggested that social support also boosts the body’s ability to 
fight the disease.  Levy et al found that a substantial amount of the variance in natural killer cell 
activity in 25 to 70 year old women diagnosed with localized and regional stage breast cancer 
was explained by the presence or absence of quality emotional support from a spouse or 
intimate partner.72  Cortisol, a reliable measure of physiologic stress, which has been shown to 
accelerate tumor cell growth in humans, has also been studied as a potential pathway for the 
influence of social support on cancer survival.  The clinical implications are not entirely clear, 
but among women with distant stage breast cancer, those reporting stronger social support 
(based on size and quality of networks) had lower mean salivary cortisol levels, likely an 
indication of better neuroendocrine functioning.73  While stress associated with limited social 
support networks may or may not have any influence on the initial development of a tumor, it 
appears that there are plausible pathways through which the presence of support in a time of 
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need may serve to diminish or blunt the influences of endocrine system changes associated 
with tumor cell proliferation.71                                      
Limitations 
There are certain limitations that should be considered while interpreting these results.  
Enhanced availability of patient-level information would increase the potential to draw more 
definitive conclusions from the findings in each of the 3 cancer patient cohorts.  The SEER 
registry data do not provide individual-level socioeconomic variables, such as personal or 
household income, educational attainment, or occupational class.  Ecological variables may 
serve as proxies for these variables, an approach others have implemented in similar studies, 
but this method increases the potential for bias.39,40,43,74  Nonetheless, ecological variables for 
income, education, and select cancer screening behaviors were considered during the 
formative stages of analysis for this study and they did not meaningfully contribute to the 
explanatory models and therefore were excluded from the final versions presented in the 
tables in this document.  Information on personal medical history, comorbidities and insurance 
status would also be extremely useful, but these variables were not available in the dataset.  A 
SEER-Medicare data linkage exists that could provide a richer collection of patient-level 
information for patients who were Medicare enrollees.  The Medicare files also contain records 
on matched ‘non-cancer’ enrollees who can be included in analysis for comparative purposes.  
Collectively, these linked datasets constitute one of the only domestic resources making it 
possible to incorporate quality of cancer care measures into population-based research.75  
However, the costs and administrative logistics associated with acquiring these additional data 
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for the current study proved to be prohibitive.  In the future, augmenting these analyses with 
Medicare data may help address certain concerns associated with confounding and effect 
modification related to medical history and comorbidities, although eligibility for--and 
inferences from--such a study would be restricted to those older than age 65 years at the time 
of diagnosis (with rare exceptions).   
The current study did not control for receipt of definitive treatment.  Although other 
researchers have taken this approach to address potential confounders, their work usually 
focused on a single tumor type.31,38  The complexities associated with determining treatment 
best practices (e.g. surgery, radiation, chemotherapy, etc.) for different cancer types when 
there is limited information available on individual medical history and tumor characteristics, 
combined with the dynamic nature of what is considered ‘best practice’ for a specific condition, 
influenced the decision to exclude this as a covariate in the current study.  If the association 
between marital status and cancer outcomes is investigated further for any of these 3 cancer 
types individually, it might be more feasible and would be useful to assess what is considered 
best practice treatment during the study period and incorporate that variable into multiple 
regression models.   
An additional limitation is the lack of information related to marital transitions (e.g. 
divorce, widowing, and marriage) that occur after the baseline status measurement but prior to 
the end of the follow-up period.  The recorded value of the primary predictor variable does not 
vary with time in this study, even if the patient undergoes a marital transition.  However, given 
that most of these patients are relatively advanced in age, it’s likely that the majority of the 
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marital transitions in these cohorts would be in the direction of widowhood, or perhaps to a 
lesser extent, divorce or separation.38  Assuming that there is such misclassification and that the 
findings in the current study are accurate, then the true size of marriage’s protective effect 
would be underestimated.  Research has suggested that failure to update patient marital status 
in longitudinal studies of its association with health outcomes does actually diminish the effect 
size observed in statistical analysis.76   
Another important issue to consider is a lack of information on the actual quality of any 
given marriage for patients in this dataset.  If social support is one of the mechanisms 
moderating the positive association between marriage and these cancer outcomes, then there 
is the assumption that support offered within the context of a marriage generally has positive 
health effects.  Patients in healthy relationships are more capable of averting depression 
associated with a cancer diagnosis than those in relationships regarded as less emotionally 
healthy; this can mean detrimental effects on health-related quality of life (for both partners) 
for those in lower quality marriages.11,77  For those individuals in a marriage with pre-existing 
high levels of stress, strife, or depression, the net negative influence of these factors may 
negate any positive effects resulting from social support inherent to a marriage.  Future studies 
that are able to incorporate some validated measure to assess self-reported quality of marriage 
may be able to better address this concern.   
SEER is an observational database; in the current study it was possible to assess 
associations between proposed risk factors and late stage disease/risk of death, but it was not 
feasible to make conclusions about the causal nature or directionality of observed correlations.  
93 
 
Simply put, it is impossible to say with any certainty whether being unmarried causes inferior 
colorectal, breast, and cervical cancer outcomes.  It can only be stated that being unmarried is 
associated with these outcomes, and then provide evidence supporting the existence of 
plausible causal mechanisms involved in these associations.   
Cancer-specific survival was the primary outcome measure used in this study.  
Determining the appropriate method for defining patient failure in survival analysis can be 
difficult.53  One argument against using cause-specific survival is the potential for 
misclassification of the cause of death, which could bias survival estimates.78  While 
acknowledging the potential for this problem in the current study, research has found SEER 
registry cause of death designations to be highly accurate and death from any cancer (as 
opposed to tumor-specific) to be an appropriate survival measure in older patient populations 
with a relatively high risk of death from competing non-cancer conditions, which would not be 
censored in analysis assessing overall survival.60             
Conclusions 
The association between marital status and health outcomes is complex, and it is likely 
that whether an individual is married or not can affect health, and in turn be affected by it.79  
Research that does not acknowledge and investigate this complex relationship could result in 
erroneous results and lead to faulty conclusions regarding the influence of marriage on health.  
There is broad public and scientific interest in determining whether social factors such as 
marriage influence the development or progression of cancer.71  Researchers have long held 
that marriage is favorably associated with health, with most acknowledging some combination 
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of selection and social causation effects as the primary drivers of the beneficial 
association.41,79,80  Goodwin and colleagues are generally credited with first identifying a 
protective effect of marriage on survival in cancer patients.39  However, much of the research 
on this topic has been devoted to cancers for which there are no proven early detection 
methods recommended for average-risk adults.11,13,31,39,40,74,81  Based on a review of the 
literature, the current study appears to be the first in which this relationship has been assessed 
in a contemporary United States population for the 3 cancers with definitive screening 
recommendations.  If differing forms of social causation play a role in the protective 
associations observed in current study, then it’s likely that we as a society can reduce this 
disparity through tailored interventions and educational programs.  While these data do not 
allow for conclusions on causal mechanisms, simply knowing that the presence or absence of 
marriage can have a substantial impact on cancer-specific survival at the population level could 
serve as a motivator for action.   
There are numerous factors influencing the association between marriage and cancer 
outcomes.  These may include substance abuse, diet, physical activity, insurance status, mental 
health, and hospital care.  Because this study focused on cancers detectable through routine 
screening, these data coupled with complementary behavioral research may be most useful 
when viewed through the lens of preventive health services’ influence on the marital 
status/cancer relationship.  In a comprehensive literature review of the effects of marriage on 
general health, Wood et al found limited research on relationships between marital status and 
utilization of preventive health services.79  While there are no nationally representative data 
connecting marital transitions and changes in the use of cancer-related preventive services, Lee 
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at al found that among female nurses age 46 to 71 who had received a mammogram during the 
previous 2 years, transitions out of marriage (widowing or divorce) were associated with an 
approximately 25% higher likelihood of women skipping regular breast cancer screening during 
the next 4 years (adjusted OR=1.27, 95% CI 0.94-1.73 in divorced, OR=1.24, 95% CI 1.07-1.44 in 
widowed).82  Interestingly, remarrying did not alter the already lower likelihood that these 
women would skip routine breast cancer screening in the near future.  This finding suggests 
that the likelihood of screening for cancer may not simply be associated with getting and 
staying married, but also (or perhaps, rather) with the presence or absence of anguish or stress 
resulting from the loss of a spouse or partner.  Wood’s contemporary literature review of the 
topic suggests that there is some support for this theory in research focused on other types of 
cancer screening, but most other methodologies are cross-sectional and/or descriptive.  They 
conclude by calling for an expansion of the representativeness of research on marital status and 
use of cancer-related preventive services.79  While the results of the current study certainly 
enhance our ability to characterize the disparity in outcomes between married and the non-
married colorectal, breast, and cervical cancer patients, additional person-level information on 
use of preventive services as well as other important variables could certainly solidify our 
understanding of the issue, and improve our ability to find actionable items in the causal 
pathway(s) for future research, policy and interventions. 
Ongoing implementation of healthcare reform creates an opportunity for public health 
to enhance its role as a national leader in cancer prevention and control.  Screening for 
colorectal, breast, and cervical cancer saves lives, but there are still disparities in the uptake of 
clinical preventive health services.  There has been no improvement in national rates of 
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screening for breast and cervical cancer during the last decade, and scarcely more than half of 
adults adhere to recommended colorectal cancer screening guidelines.23,83  While the current 
study does not account for differences in screening rates, we know that within this population, 
non-married adults are generally diagnosed with later stage cancer and have shorter survival, 
suggesting that early detection plays a role.  The Patient Protection and Affordable Care Act will 
address traditional barriers such as lack of insurance through expansion of social safety nets for 
the poor and subsidized insurance exchanges for those in the working class, but 
complementary initiatives could target those who still do not actively pursue clinical preventive 
services.83  The limitations of the current study may actually highlight opportunities for 
improvements in the infrastructure of cancer prevention.  Currently, the best data available on 
the prevalence of cancer screening in the United States come from self-reported telephone-
based surveys administered regularly over time.  Registries such as SEER, however, 
comprehensively document events (in SEER’s case, cancer outcomes) as they occur.  With the 
substantial expansion of insurance coverage promised by health reform, there may be an 
opportunity to link Medicare, Medicaid, state insurance exchange, and other health benefits 
data to monitor preventive health behavior comprehensively at the individual level, and in real 
time.  Special populations with poor health outcomes (such as non-married adults within the 
age range for cancer screening) might benefit from targeted programs designed to improve 
screening uptake and clinical follow-up while also monitoring treatment decisions and cancer-
specific outcomes.                             
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APPENDICES 
APPENDIX A 
Assessing Sex as an Effect Modifier of Stage at Diagnosis in Colorectal Cancer Patients 
Baseline category logit analysis of marital status and other factors predicting colorectal cancer 
stage at diagnosis in male patients, SEER cancer registries, 2004 through 2006 diagnoses,    
n=47 524 
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Baseline category logit analysis of marital status and other factors predicting colorectal cancer 
stage at diagnosis in female patients, SEER cancer registries, 2004 through 2006 diagnoses, 
n=45 181 
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APPENDIX B 
Assessing Race as an Effect Modifier of Stage at Diagnosis in Female Breast Cancer Patients 
Baseline category logit analysis of marital status and other factors predicting female breast 
cancer stage at diagnosis in white patients, SEER cancer registries, 2004-2006 diagnoses,    
n=117 907 
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Baseline category logit analysis of marital status and other factors predicting female breast 
cancer stage at diagnosis in black patients, SEER cancer registries, 2004-2006 diagnoses,      
n=13 677 
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Baseline category logit analysis of marital status and other factors predicting female breast 
cancer stage at diagnosis in patients classified as ‘other’ race, SEER cancer registries, 2004-2006 
diagnoses, n=9 977 
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APPENDIX C 
Assessing Sex as an Effect Modifier of Survival in Colorectal Cancer Patients 
Multivariate Cox proportional hazards model for marital status and other variables predicting 
death from any cancer among male colorectal cancer patients, SEER cancer registries, 2004-
2006 diagnoses, n=47 524 
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Multivariate Cox proportional hazards model for marital status and other variables predicting 
death from any cancer among female colorectal cancer patients, SEER cancer registries, 2004-
2006 diagnoses, n=45 183 
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APPENDIX D 
Assessing Race as an Effect Modifier of Survival in Female Breast Cancer Patients 
Multivariate Cox proportional hazards model for marital status and other variables predicting 
death from any cancer among white female breast cancer patients, SEER cancer registries, 
2004-2006 diagnoses, n=117 907 
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Multivariate Cox proportional hazards model for marital status and other variables predicting 
death from any cancer among black female breast cancer patients, SEER cancer registries, 2004-
2006 diagnoses, n=13 677 
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Multivariate Cox proportional hazards model for marital status and other variables predicting 
death from any cancer among female breast cancer patients classified as ‘other’ race, SEER 
cancer registries, 2004-2006 diagnoses, n=9 977 
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